{"protocolSection": {"identificationModule": {"nctId": "NCT00121641", "orgStudyIdInfo": {"id": "CV181-011"}, "organization": {"fullName": "AstraZeneca", "class": "INDUSTRY"}, "briefTitle": "Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise", "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise"}, "statusModule": {"statusVerifiedDate": "2015-03", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2005-07"}, "primaryCompletionDateStruct": {"date": "2006-08", "type": "ACTUAL"}, "completionDateStruct": {"date": "2010-02", "type": "ACTUAL"}, "studyFirstSubmitDate": "2005-07-15", "studyFirstSubmitQcDate": "2005-07-15", "studyFirstPostDateStruct": {"date": "2005-07-21", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2011-04-12", "resultsFirstSubmitQcDate": "2011-04-12", "resultsFirstPostDateStruct": {"date": "2011-05-11", "type": "ESTIMATED"}, "dispFirstSubmitDate": "2009-07-30", "dispFirstSubmitQcDate": "2009-11-12", "dispFirstPostDateStruct": {"date": "2010-03-04", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2015-03-16", "lastUpdatePostDateStruct": {"date": "2015-04-03", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "AstraZeneca", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "The purpose of this clinical research study is to learn whether saxagliptin (BMS-477118) is more effective than placebo as a treatment for type 2 diabetic subjects who are not sufficiently controlled with diet and exercise", "detailedDescription": "All subjects will participate in a lead-in period, and qualifying subjects will continue into a short-term randomized treatment period. Subjects who complete the short-term period will be eligible to enter the long term extension period. Also, subjects in the short-term period who have an elevated blood sugar that requires additional medication for blood sugar control will be eligible to enter the long-term treatment extension period where they will receive metformin added onto their blinded study medication. Subjects with screening hemoglobin A1c (A1C) \\> 10.0% and \u2264 12.0%, who otherwise meet all inclusion/exclusion criteria, were eligible to enroll directly into Open-Label Treatment Cohort (Direct Enrollees) and receive open-label saxagliptin 10 mg. Those who completed the short-term period were eligible to enter into the long-term treatment extension period.Saxagliptin dose titration was not permitted."}, "conditionsModule": {"conditions": ["Diabetes Mellitus, Type 2"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 1035, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Saxagliptin 2.5 mg (A)", "type": "EXPERIMENTAL", "description": "Metformin 500-2000 mg (as needed for rescue)", "interventionNames": ["Drug: Saxagliptin", "Drug: Placebo matching Metformin", "Drug: Metformin"]}, {"label": "Saxagliptin 5 mg (B)", "type": "EXPERIMENTAL", "description": "Metformin 500-2000 mg (as needed for rescue)", "interventionNames": ["Drug: Saxagliptin", "Drug: Placebo matching Metformin", "Drug: Metformin"]}, {"label": "Saxagliptin 10 mg (C)", "type": "EXPERIMENTAL", "description": "Metformin 500-2000 mg (as needed for rescue)", "interventionNames": ["Drug: Saxagliptin", "Drug: Placebo matching Metformin", "Drug: Metformin"]}, {"label": "Placebo (D)", "type": "PLACEBO_COMPARATOR", "description": "Metformin 500-2000 mg (as needed for rescue)", "interventionNames": ["Drug: Placebo matching Saxagliptin", "Drug: Metformin"]}, {"label": "Open-Label Treatment Cohort (Direct Enrollees) (E)", "type": "EXPERIMENTAL", "description": "Saxagliptin 10 mg\n\nMetformin 500-2000 mg (as needed for rescue)", "interventionNames": ["Drug: Saxagliptin", "Drug: Metformin"]}], "interventions": [{"type": "DRUG", "name": "Saxagliptin", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks short term \\[ST\\], 42 months long term \\[LT\\])", "armGroupLabels": ["Saxagliptin 2.5 mg (A)"], "otherNames": ["BMS-477118"]}, {"type": "DRUG", "name": "Saxagliptin", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT)", "armGroupLabels": ["Saxagliptin 5 mg (B)"], "otherNames": ["BMS-477118"]}, {"type": "DRUG", "name": "Saxagliptin", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT)", "armGroupLabels": ["Saxagliptin 10 mg (C)"], "otherNames": ["BMS-477118"]}, {"type": "DRUG", "name": "Placebo matching Saxagliptin", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT)", "armGroupLabels": ["Placebo (D)"]}, {"type": "DRUG", "name": "Metformin", "description": "Tablets, Oral, 500 mg, daily (42 months LT)", "armGroupLabels": ["Placebo (D)"]}, {"type": "DRUG", "name": "Placebo matching Metformin", "description": "Tablets, Oral, 0 mg, daily (42 months LT)", "armGroupLabels": ["Saxagliptin 10 mg (C)", "Saxagliptin 2.5 mg (A)", "Saxagliptin 5 mg (B)"]}, {"type": "DRUG", "name": "Saxagliptin", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT) Open Label", "armGroupLabels": ["Open-Label Treatment Cohort (Direct Enrollees) (E)"], "otherNames": ["BMS-477118"]}, {"type": "DRUG", "name": "Metformin", "description": "Tablets, Oral, 500-2000 mg (as needed for rescue)", "armGroupLabels": ["Open-Label Treatment Cohort (Direct Enrollees) (E)", "Placebo (D)", "Saxagliptin 10 mg (C)", "Saxagliptin 2.5 mg (A)", "Saxagliptin 5 mg (B)"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Hemoglobin A1c (A1C) Changes From Baseline at Week 24", "description": "To compare the change from baseline in HbA1c achieved with each dose of saxagliptin versus placebo in treatment naive subjects with type 2 diabetes who have inadequate glycemic control defined as A1C \u22657.0% and \u226410.0%.", "timeFrame": "Baseline, Week 24"}, {"measure": "A1C Changes From Baseline at Week 24 - Open Label Cohort", "description": "To compare the change from baseline in HbA1c achieved with each dose of saxagliptin versus placebo in treatment naive subjects with type 2 diabetes who have inadequate glycemic control defined as A1C \u22657.0% and \u226410.0%.", "timeFrame": "Baseline, Week 24"}], "secondaryOutcomes": [{"measure": "Baseline and Change From Baseline at Week 24 in Fasting Plasma Glucose (FPG)", "timeFrame": "Baseline, Week 24"}, {"measure": "Percentage of Participants Achieving Therapeutic Glycemic Response (A1C < 7.0%) at Week 24", "timeFrame": "Week 24"}, {"measure": "Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC)", "timeFrame": "Baseline, Week 24"}, {"measure": "Baseline and Change From Baseline at Week 24 in Fasting Plasma Glucose (FPG) - Open Label Cohort", "timeFrame": "Baseline, Week 24"}, {"measure": "Percentage of Participants Achieving Therapeutic Glycemic Response (A1C < 7.0%) at Week 24 - Open Label Cohort", "timeFrame": "Week 24"}, {"measure": "Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC) - Open Label Cohort", "timeFrame": "Baseline, Week 24"}], "otherOutcomes": [{"measure": "Baseline Demographic Characteristic (Age, Continuous) - Summary for ST + LT Treatment Period - Open-Label Cohort", "description": "This cohort represents a different population (screening A1C \\> 10.0% and \u2264 12.0%) than the double-blind cohort, and was presented separately in the study report.", "timeFrame": "Baseline"}, {"measure": "Baseline Demographic Characteristics - Summary for ST + LT Treatment Period - Open-Label Cohort", "description": "This cohort represents a different population (screening A1C \\> 10.0% and \u2264 12.0%) than the double-blind cohort, and was presented separately in the study report.", "timeFrame": "Baseline"}, {"measure": "Baseline Demographic Characteristic (Weight) - Summary for ST + LT Treatment Period - Open-Label Cohort", "description": "This cohort represents a different population (screening A1C \\> 10.0% and \u2264 12.0%) than the double-blind cohort, and was presented separately in the study report.", "timeFrame": "Baseline"}, {"measure": "Baseline Demographic Characteristic (Body Mass Index) - Summary for ST + LT Treatment Period - Open-Label Cohort", "description": "This cohort represents a different population (screening A1C \\> 10.0% and \u2264 12.0%) than the double-blind cohort, and was presented separately in the study report.", "timeFrame": "Baseline"}, {"measure": "Overall Summary of Adverse Events During ST+LT Treatment Period", "description": "AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm."}, {"measure": "Marked Laboratory Abnormalities - During ST + LT Treatment Period", "description": "A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: \\<0.9 x Pre-Rx \\& \\<=130mEq/L / high: \\>1.1 x Pre-Rx \\& \\>=150mEq/L; potassium, serum low: \\<=0.8 x Pre-Rx \\& \\>=6.0mEq/L / high: 1.2 x Pre-Rx \\& \\>=6.0mEq/L; LLN=lower limit of normal.", "timeFrame": "Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm."}, {"measure": "Baseline and Changes From Baseline in Hemoglobin During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Hematocrit During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Red Blood Cell Counts (x 10^6 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Platelet Counts (x 10^9 c/L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in White Blood Cell Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Absolute Neutrophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Absolute Lymphocyte Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Absolute Monocyte Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Absolute Basophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Absolute Eosinophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Changes From Baseline in Systolic Blood Pressure During the ST + LT Period", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Changes From Baseline in Heart Rate During the ST + LT Period", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period", "description": "The normality/abnormality of the ECG tracing was determined by the investigator.", "timeFrame": "Baseline, Weeks 12, 24, 76, 102, 154, 206"}, {"measure": "Overall Summary of Adverse Events During ST+LT Treatment Period - Open-Label Cohort", "description": "AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks."}, {"measure": "Marked Laboratory Abnormalities During ST + LT Treatment Period - Open-Label Cohort", "description": "A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: \\<0.9 x Pre-Rx \\& \\<=130mEq/L / high: \\>1.1 x Pre-Rx \\& \\>=150mEq/L; potassium, serum low: \\<=0.8 x Pre-Rx \\& \\>=6.0mEq/L / high: 1.2 x Pre-Rx \\& \\>=6.0mEq/L; LLN=lower limit of normal.", "timeFrame": "Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure was 34 weeks."}, {"measure": "All Reported Hypoglycemic Adverse Events During ST + LT Treatment Period", "description": "Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which included hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm."}, {"measure": "Confirmed Hypoglycemia During ST + LT Treatment Period", "description": "'Confirmed' = recorded on the hypoglycemia AE case report form page with a fingerstick glucose \\<= 50 mg/dL and associated symptoms", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm."}, {"measure": "All Reported Hypoglycemic Adverse Events During ST + LT Treatment Period - Open-Label Cohort", "description": "Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which included hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks."}, {"measure": "Confirmed Hypoglycemia During ST + LT Treatment Period - Open-Label Cohort", "description": "'Confirmed' = recorded on the hypoglycemia AE case report form page with a fingerstick glucose \\<= 50 mg/dL and associated symptoms", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks."}, {"measure": "Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period - Open Label Cohort", "description": "The normality/abnormality of the ECG tracing was determined by the investigator.", "timeFrame": "Baseline, Weeks 12, 24, 76, 102, 154, 206"}, {"measure": "Changes From Baseline in Systolic Blood Pressure During the ST + LT Period - Open Label Cohort", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167"}, {"measure": "Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period - Open Label Cohort", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167"}, {"measure": "Changes From Baseline in Heart Rate During the ST + LT Period - Open Label Cohort", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Type 2 diabetes mellitus\n* Drug naive\n* Hemoglobin (Hb) A1c \\>= 7.0% and \\<= 10.0% (\\>10% and \\<= 12% for open label arm)\n* Fasting C-peptide \\>= 1 ng/mL\n* Body mass index \\<= 40 kg/m2\n\nExclusion Criteria:\n\n* Symptomatic poorly controlled diabetes\n* Recent cardiac or cerebrovascular event\n* Serum creatinine \\>= 1.5 mg/dL for males and \\>= 1.4 mg/dL for Women of Child Bearing Potential", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "77 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Local Institution", "city": "Anniston", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.65983, "lon": -85.83163}}, {"facility": "Local Institution", "city": "Birmingham", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "Local Institution", "city": "Calera", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.1029, "lon": -86.7536}}, {"facility": "Local Institution", "city": "Jonesboro", "state": "Arizona", "country": "United States"}, {"facility": "Local Institution", "city": "Mesa", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.42227, "lon": -111.82264}}, {"facility": "Local Institution", "city": "Pheonix", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "Local Institution", "city": "Little Rock", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "Local Institution", "city": "Anaheim", "state": "California", "country": "United States", "geoPoint": {"lat": 33.83529, "lon": -117.9145}}, {"facility": "Local Institution", "city": "Fountain Valley", "state": "California", "country": "United States", "geoPoint": {"lat": 33.70918, "lon": -117.95367}}, {"facility": "Local Institution", "city": "Fresno", "state": "California", "country": "United States", "geoPoint": {"lat": 36.74773, "lon": -119.77237}}, {"facility": "Local Institution", "city": "Long Beach", "state": "California", "country": "United States", "geoPoint": {"lat": 33.76696, "lon": -118.18923}}, {"facility": "Local Institution", "city": "Los Angeles", "state": "California", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "Local Institution", "city": "Northridge", "state": "California", "country": "United States", "geoPoint": {"lat": 34.22834, "lon": -118.53675}}, {"facility": "Local Institution", "city": "Rolling Hills Estates", "state": "California", "country": "United States", "geoPoint": {"lat": 33.78779, "lon": -118.35813}}, {"facility": "Local Institution", "city": "Sacramento", "state": "California", "country": "United States", "geoPoint": {"lat": 38.58157, "lon": -121.4944}}, {"facility": "Local Institution", "city": "Santa Ana", "state": "California", "country": "United States", "geoPoint": {"lat": 33.74557, "lon": -117.86783}}, {"facility": "Local Institution", "city": "Spring Valley", "state": "California", "country": "United States", "geoPoint": {"lat": 32.74477, "lon": -116.99892}}, {"facility": "Local Institution", "city": "Tustin", "state": "California", "country": "United States", "geoPoint": {"lat": 33.74585, "lon": -117.82617}}, {"facility": "Local Institution", "city": "Castle Rock", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 39.37221, "lon": -104.85609}}, {"facility": "Local Institution", "city": "Denver", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"facility": "Local Institution", "city": "Loveland", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 40.39776, "lon": -105.07498}}, {"facility": "Local Institution", "city": "Altamonte Springs", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.66111, "lon": -81.36562}}, {"facility": "Local Institution", "city": "Chipley", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.78186, "lon": -85.53854}}, {"facility": "Local Institution", "city": "Cocoa Beach", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.32045, "lon": -80.60947}}, {"facility": "Local Institution", "city": "Coral Gables", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.72149, "lon": -80.26838}}, {"facility": "Local Institution", "city": "Fort Lauderdale", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.12231, "lon": -80.14338}}, {"facility": "Local Institution", "city": "Jupiter", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.93422, "lon": -80.09421}}, {"facility": "Local Institution", "city": "Kissimmee", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.30468, "lon": -81.41667}}, {"facility": "Local Institution", "city": "Marianna", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.77436, "lon": -85.22687}}, {"facility": "Local Institution", "city": "New Port Richey", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.24418, "lon": -82.71927}}, {"facility": "Local Institution", "city": "Ocala", "state": "Florida", "country": "United States", "geoPoint": {"lat": 29.1872, "lon": -82.14009}}, {"facility": "Local Institution", "city": "West Palm Beach", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.71534, "lon": -80.05337}}, {"facility": "Local Institution", "city": "Vernon Hills", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 42.21947, "lon": -87.97952}}, {"facility": "Local Institution", "city": "Dubuque", "state": "Iowa", "country": "United States", "geoPoint": {"lat": 42.50056, "lon": -90.66457}}, {"facility": "Local Institution", "city": "Iowa City", "state": "Iowa", "country": "United States", "geoPoint": {"lat": 41.66113, "lon": -91.53017}}, {"facility": "Local Institution", "city": "Waterloo", "state": "Iowa", "country": "United States", "geoPoint": {"lat": 42.49276, "lon": -92.34296}}, {"facility": "Local Institution", "city": "Wichita", "state": "Kansas", "country": "United States", "geoPoint": {"lat": 37.69224, "lon": -97.33754}}, {"facility": "Local Institution", "city": "Lexington", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "Local Institution", "city": "Munfordville", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 37.27228, "lon": -85.89108}}, {"facility": "Local Institution", "city": "New Orleans", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 29.95465, "lon": -90.07507}}, {"facility": "Local Institution", "city": "West Monroe", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 32.51848, "lon": -92.14764}}, {"facility": "Local Institution", "city": "Baltimore", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"facility": "Local Institution", "city": "Chester", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 38.97539, "lon": -76.2894}}, {"facility": "Local Institution", "city": "Prince Frederick", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 38.5404, "lon": -76.5844}}, {"facility": "Local Institution", "city": "Ayer", "state": "Massachusetts", "country": "United States", "geoPoint": {"lat": 42.5612, "lon": -71.58979}}, {"facility": "Local Institution", "city": "Boston", "state": "Massachusetts", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "Local Institution", "city": "Rolling Fork", "state": "Mississippi", "country": "United States", "geoPoint": {"lat": 32.90652, "lon": -90.87816}}, {"facility": "Local Institution", "city": "Kansas City", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 39.09973, "lon": -94.57857}}, {"facility": "Local Institution", "city": "Springfield", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 37.21533, "lon": -93.29824}}, {"facility": "Local Institution", "city": "St. Louis", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "Local Institution", "city": "Kalispell", "state": "Montana", "country": "United States", "geoPoint": {"lat": 48.19579, "lon": -114.31291}}, {"facility": "Local Institution", "city": "Omaha", "state": "Nebraska", "country": "United States", "geoPoint": {"lat": 41.25626, "lon": -95.94043}}, {"facility": "Local Institution", "city": "Las Vegas", "state": "Nevada", "country": "United States", "geoPoint": {"lat": 36.17497, "lon": -115.13722}}, {"facility": "Local Institution", "city": "Middletown", "state": "New Jersey", "country": "United States", "geoPoint": {"lat": 40.39652, "lon": -74.09211}}, {"facility": "Local Institution", "city": "Toms River", "state": "New Jersey", "country": "United States", "geoPoint": {"lat": 39.95373, "lon": -74.19792}}, {"facility": "Local Institution", "city": "Cooperstown", "state": "New York", "country": "United States", "geoPoint": {"lat": 42.70048, "lon": -74.92426}}, {"facility": "Local Institution", "city": "Greensboro", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 36.07264, "lon": -79.79198}}, {"facility": "Local Institution", "city": "Huntersville", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.41069, "lon": -80.84285}}, {"facility": "Local Institution", "city": "Sparta", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 36.50541, "lon": -81.12092}}, {"facility": "Local Institution", "city": "Statesville", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.78264, "lon": -80.8873}}, {"facility": "Local Institution", "city": "Winston Salem", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 36.09986, "lon": -80.24422}}, {"facility": "Local Institution", "city": "Athens", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.32924, "lon": -82.10126}}, {"facility": "Local Institution", "city": "Franklin", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.55895, "lon": -84.30411}}, {"facility": "Local Institution", "city": "Oklahoma City", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "Local Institution", "city": "Tulsa", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 36.15398, "lon": -95.99277}}, {"facility": "Local Institution", "city": "Portland", "state": "Oregon", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "Local Institution", "city": "Fleetwood", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.45398, "lon": -75.81798}}, {"facility": "Local Institution", "city": "Philadelphia", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Local Institution", "city": "Pittsburgh", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Local Institution", "city": "Charleston", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"facility": "Local Institution", "city": "Bristol", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.59511, "lon": -82.18874}}, {"facility": "Local Institution", "city": "Morristown", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.21398, "lon": -83.29489}}, {"facility": "Local Institution", "city": "Bryan", "state": "Texas", "country": "United States", "geoPoint": {"lat": 30.67436, "lon": -96.36996}}, {"facility": "Local Institution", "city": "Dallas", "state": "Texas", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "Local Institution", "city": "Fort Worth", "state": "Texas", "country": "United States", "geoPoint": {"lat": 32.72541, "lon": -97.32085}}, {"facility": "Local Institution", "city": "Houston", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Local Institution", "city": "San Antonio", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "Local Institution", "city": "Temple", "state": "Texas", "country": "United States", "geoPoint": {"lat": 31.09823, "lon": -97.34278}}, {"facility": "Local Institution", "city": "Texarkana", "state": "Texas", "country": "United States", "geoPoint": {"lat": 33.42513, "lon": -94.04769}}, {"facility": "Local Institution", "city": "The Colony", "state": "Texas", "country": "United States", "geoPoint": {"lat": 33.08901, "lon": -96.88639}}, {"facility": "Local Institution", "city": "Salt Lake City", "state": "Utah", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"facility": "Local Institution", "city": "Virginia Beach", "state": "Virginia", "country": "United States", "geoPoint": {"lat": 36.85293, "lon": -75.97799}}, {"facility": "Local Institution", "city": "Olympia", "state": "Washington", "country": "United States", "geoPoint": {"lat": 47.03787, "lon": -122.9007}}, {"facility": "Local Institution", "city": "Sydney", "state": "New South Wales", "country": "Australia", "geoPoint": {"lat": -33.86785, "lon": 151.20732}}, {"facility": "Local Institution", "city": "Woollongong", "state": "New South Wales", "country": "Australia"}, {"facility": "Local Institution", "city": "Brisbane", "state": "Queensland", "country": "Australia", "geoPoint": {"lat": -27.46794, "lon": 153.02809}}, {"facility": "Local Institution", "city": "Kippa Ring", "state": "Queensland", "country": "Australia", "geoPoint": {"lat": -27.22586, "lon": 153.0835}}, {"facility": "Local Institution", "city": "Meadowbrook", "state": "Queensland", "country": "Australia", "geoPoint": {"lat": -27.66401, "lon": 153.14465}}, {"facility": "Local Institution", "city": "Adelaide", "state": "South Australia", "country": "Australia", "geoPoint": {"lat": -34.92866, "lon": 138.59863}}, {"facility": "Local Institution", "city": "Woodville South", "state": "South Australia", "country": "Australia", "geoPoint": {"lat": -34.88186, "lon": 138.53477}}, {"facility": "Local Institution", "city": "Perth", "state": "Western Australia", "country": "Australia", "geoPoint": {"lat": -31.95224, "lon": 115.8614}}, {"facility": "Local Institution", "city": "Calgary", "state": "Alberta", "country": "Canada", "geoPoint": {"lat": 51.05011, "lon": -114.08529}}, {"facility": "Local Institution", "city": "Edmonton", "state": "Alberta", "country": "Canada", "geoPoint": {"lat": 53.55014, "lon": -113.46871}}, {"facility": "Local Institution", "city": "Kelowna", "state": "British Columbia", "country": "Canada", "geoPoint": {"lat": 49.88307, "lon": -119.48568}}, {"facility": "Local Institution", "city": "Quesnel", "state": "British Columbia", "country": "Canada", "geoPoint": {"lat": 52.97842, "lon": -122.4931}}, {"facility": "Local Institution", "city": "Vancouver", "state": "British Columbia", "country": "Canada", "geoPoint": {"lat": 49.24966, "lon": -123.11934}}, {"facility": "Local Institution", "city": "Portage La Prairie", "state": "Manitoba", "country": "Canada", "geoPoint": {"lat": 49.97282, "lon": -98.29263}}, {"facility": "Local Institution", "city": "Winnipeg", "state": "Manitoba", "country": "Canada", "geoPoint": {"lat": 49.8844, "lon": -97.14704}}, {"facility": "Local Institution", "city": "Bathurst", "state": "New Brunswick", "country": "Canada", "geoPoint": {"lat": 47.61814, "lon": -65.65112}}, {"facility": "Local Institution", "city": "Moncton", "state": "New Brunswick", "country": "Canada", "geoPoint": {"lat": 46.09454, "lon": -64.7965}}, {"facility": "Local Institution", "city": "Manuels", "state": "Newfoundland and Labrador", "country": "Canada"}, {"facility": "Local Institution", "city": "Mount Pearl", "state": "Newfoundland and Labrador", "country": "Canada", "geoPoint": {"lat": 47.51659, "lon": -52.78135}}, {"facility": "Local Institution", "city": "St. John's", "state": "Newfoundland and Labrador", "country": "Canada", "geoPoint": {"lat": 47.56494, "lon": -52.70931}}, {"facility": "Local Institution", "city": "Newmarket", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 44.05011, "lon": -79.46631}}, {"facility": "Local Institution", "city": "Oakville", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 43.45011, "lon": -79.68292}}, {"facility": "Local Institution", "city": "Peterborough", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 44.30012, "lon": -78.31623}}, {"facility": "Local Institution", "city": "Sarnia", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 42.97866, "lon": -82.40407}}, {"facility": "Local Institution", "city": "Strathroy", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 42.9551, "lon": -81.62232}}, {"facility": "Local Institution", "city": "Thornhill", "state": "Ontario", "country": "Canada"}, {"facility": "Local Institution", "city": "Toronto", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"facility": "Local Institution", "city": "Charlottetown", "state": "Prince Edward Island", "country": "Canada", "geoPoint": {"lat": 46.23899, "lon": -63.13414}}, {"facility": "Local Institution", "city": "Drummondville", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.88336, "lon": -72.48241}}, {"facility": "Local Institution", "city": "Fleurimont", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.41455, "lon": -71.84873}}, {"facility": "Local Institution", "city": "Gatineau", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.47723, "lon": -75.70164}}, {"facility": "Local Institution", "city": "Granby", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.40008, "lon": -72.73243}}, {"facility": "Local Institution", "city": "Longueuil", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.53121, "lon": -73.51806}}, {"facility": "Local Institution", "city": "Montreal", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "Local Institution", "city": "St. Leonard", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.58773, "lon": -73.59501}}, {"facility": "Local Institution", "city": "Ste-Foy", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 46.75615, "lon": -71.29543}}, {"facility": "Local Institution", "city": "Saskatoon", "state": "Saskatchewan", "country": "Canada", "geoPoint": {"lat": 52.13238, "lon": -106.66892}}, {"facility": "Local Institution", "city": "Mexico City", "state": "Distrito Federal", "country": "Mexico", "geoPoint": {"lat": 19.42847, "lon": -99.12766}}, {"facility": "Local Institution", "city": "Mexico D.F.", "state": "Distrito Federal", "country": "Mexico"}, {"facility": "Local Institution", "city": "Guadalajara", "state": "Jalisco", "country": "Mexico", "geoPoint": {"lat": 20.66682, "lon": -103.39182}}, {"facility": "Local Institution", "city": "Monterrey", "state": "Nuevo Leon", "country": "Mexico", "geoPoint": {"lat": 25.67507, "lon": -100.31847}}, {"facility": "Local Institution", "city": "Hermosillo", "state": "Sonora", "country": "Mexico", "geoPoint": {"lat": 29.1026, "lon": -110.97732}}, {"facility": "Local Institution", "city": "Aguascalientes", "country": "Mexico", "geoPoint": {"lat": 21.88234, "lon": -102.28259}}, {"facility": "Local Institution", "city": "Durango", "country": "Mexico", "geoPoint": {"lat": 24.02032, "lon": -104.65756}}, {"facility": "Local Institution", "city": "Carolina", "country": "Puerto Rico", "geoPoint": {"lat": 18.38078, "lon": -65.95739}}, {"facility": "Local Institution", "city": "Guaynabo", "country": "Puerto Rico", "geoPoint": {"lat": 18.35745, "lon": -66.111}}, {"facility": "Local Institution", "city": "Ponce", "country": "Puerto Rico", "geoPoint": {"lat": 18.01108, "lon": -66.61406}}, {"facility": "Local Institution", "city": "Rio Piedras", "country": "Puerto Rico", "geoPoint": {"lat": 18.39745, "lon": -66.04989}}, {"facility": "Local Institution", "city": "San Juan", "country": "Puerto Rico", "geoPoint": {"lat": 18.46633, "lon": -66.10572}}, {"facility": "Local Institution", "city": "Hualien", "country": "Taiwan"}, {"facility": "Local Institution", "city": "Taichung", "country": "Taiwan", "geoPoint": {"lat": 24.1469, "lon": 120.6839}}, {"facility": "Local Institution", "city": "Taipei", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}]}, "referencesModule": {"references": [{"pmid": "19650754", "type": "BACKGROUND", "citation": "Rosenstock J, Aguilar-Salinas C, Klein E, Nepal S, List J, Chen R; CV181-011 Study Investigators. Effect of saxagliptin monotherapy in treatment-naive patients with type 2 diabetes. Curr Med Res Opin. 2009 Oct;25(10):2401-11. doi: 10.1185/03007990903178735."}, {"pmid": "29976228", "type": "DERIVED", "citation": "Esu E, Berens-Riha N, Pritsch M, Nwachuku N, Loescher T, Meremikwu M. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria. Malar J. 2018 Jul 6;17(1):251. doi: 10.1186/s12936-018-2394-2."}, {"pmid": "27402391", "type": "DERIVED", "citation": "Perl S, Cook W, Wei C, Iqbal N, Hirshberg B. Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment. Diabetes Ther. 2016 Sep;7(3):527-35. doi: 10.1007/s13300-016-0184-9. Epub 2016 Jul 11."}, {"pmid": "27033025", "type": "DERIVED", "citation": "Bonora E, Bryzinski B, Hirshberg B, Cook W. A post hoc analysis of saxagliptin efficacy and safety in patients with type 2 diabetes stratified by UKPDS 10-year cardiovascular risk score. Nutr Metab Cardiovasc Dis. 2016 May;26(5):374-9. doi: 10.1016/j.numecd.2015.11.004. Epub 2015 Dec 1."}, {"pmid": "23802840", "type": "DERIVED", "citation": "Rosenstock J, Gross JL, Aguilar-Salinas C, Hissa M, Berglind N, Ravichandran S, Fleming D. Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetes. Diabet Med. 2013 Dec;30(12):1472-6. doi: 10.1111/dme.12267. Epub 2013 Jul 19."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "1035 subjects were enrolled; 422 entered the 2-week dietary/exercise placebo lead-in. 21 did not enter double-blind treatment period (19 discontinued, 2 randomized but did not receive study drug). 68 with screening hemoglobin A1c (A1C) \\>10.0% and \u226412.0% entered directly in the open-label cohort; 66 received at least 1 dose of saxagliptin 10mg.", "groups": [{"id": "FG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks short term \\[ST\\], 42 months long term \\[LT\\]); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "FG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "FG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "FG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}, {"id": "FG004", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "periods": [{"title": "24-week Short-term Treatment Period", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "102"}, {"groupId": "FG001", "numSubjects": "106"}, {"groupId": "FG002", "numSubjects": "98"}, {"groupId": "FG003", "numSubjects": "95"}, {"groupId": "FG004", "numSubjects": "66"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "73"}, {"groupId": "FG001", "numSubjects": "68"}, {"groupId": "FG002", "numSubjects": "69"}, {"groupId": "FG003", "numSubjects": "55"}, {"groupId": "FG004", "numSubjects": "25"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "29"}, {"groupId": "FG001", "numSubjects": "38"}, {"groupId": "FG002", "numSubjects": "29"}, {"groupId": "FG003", "numSubjects": "40"}, {"groupId": "FG004", "numSubjects": "41"}]}], "dropWithdraws": [{"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "21"}, {"groupId": "FG002", "numSubjects": "14"}, {"groupId": "FG003", "numSubjects": "25"}, {"groupId": "FG004", "numSubjects": "30"}]}, {"type": "Subject Withdrew Consent", "reasons": [{"groupId": "FG000", "numSubjects": "9"}, {"groupId": "FG001", "numSubjects": "11"}, {"groupId": "FG002", "numSubjects": "5"}, {"groupId": "FG003", "numSubjects": "10"}, {"groupId": "FG004", "numSubjects": "3"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "2"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "3"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "4"}]}, {"type": "Poor / Non-compliance", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "3"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "1"}]}, {"type": "Subject No Longer Meets Study Criteria", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "1"}]}, {"type": "Other Reason", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}]}]}, {"title": "48-month Short Term + Long Term Period", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "102"}, {"groupId": "FG001", "numSubjects": "106"}, {"groupId": "FG002", "numSubjects": "98"}, {"groupId": "FG003", "numSubjects": "95"}, {"groupId": "FG004", "numSubjects": "66"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "23"}, {"groupId": "FG001", "numSubjects": "24"}, {"groupId": "FG002", "numSubjects": "28"}, {"groupId": "FG003", "numSubjects": "24"}, {"groupId": "FG004", "numSubjects": "8"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "79"}, {"groupId": "FG001", "numSubjects": "82"}, {"groupId": "FG002", "numSubjects": "70"}, {"groupId": "FG003", "numSubjects": "71"}, {"groupId": "FG004", "numSubjects": "58"}]}], "dropWithdraws": [{"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "26"}, {"groupId": "FG001", "numSubjects": "27"}, {"groupId": "FG002", "numSubjects": "21"}, {"groupId": "FG003", "numSubjects": "26"}, {"groupId": "FG004", "numSubjects": "25"}]}, {"type": "Subject Withdrew Consent", "reasons": [{"groupId": "FG000", "numSubjects": "25"}, {"groupId": "FG001", "numSubjects": "28"}, {"groupId": "FG002", "numSubjects": "17"}, {"groupId": "FG003", "numSubjects": "24"}, {"groupId": "FG004", "numSubjects": "10"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "9"}, {"groupId": "FG001", "numSubjects": "10"}, {"groupId": "FG002", "numSubjects": "10"}, {"groupId": "FG003", "numSubjects": "5"}, {"groupId": "FG004", "numSubjects": "5"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "9"}, {"groupId": "FG001", "numSubjects": "7"}, {"groupId": "FG002", "numSubjects": "12"}, {"groupId": "FG003", "numSubjects": "11"}, {"groupId": "FG004", "numSubjects": "12"}]}, {"type": "Poor / Non-compliance", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "2"}, {"groupId": "FG004", "numSubjects": "2"}]}, {"type": "Subject No Longer Meets Study Criteria", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "2"}]}, {"type": "Pregnancy", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}]}, {"type": "Administrative Reason by Sponsor", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "1"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}]}, {"type": "Missing", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}]}, {"type": "Other Reason", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "BG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "BG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "BG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}, {"id": "BG004", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "102"}, {"groupId": "BG001", "value": "106"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "95"}, {"groupId": "BG004", "value": "401"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "53.27", "spread": "10.06"}, {"groupId": "BG001", "value": "53.91", "spread": "11.57"}, {"groupId": "BG002", "value": "52.73", "spread": "11.27"}, {"groupId": "BG003", "value": "53.91", "spread": "12.32"}, {"groupId": "BG004", "value": "53.46", "spread": "11.29"}]}]}]}, {"title": "Age, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "<65 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "91"}, {"groupId": "BG001", "value": "86"}, {"groupId": "BG002", "value": "84"}, {"groupId": "BG003", "value": "77"}, {"groupId": "BG004", "value": "338"}]}]}, {"title": ">= 65 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "11"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "14"}, {"groupId": "BG003", "value": "18"}, {"groupId": "BG004", "value": "63"}]}]}, {"title": ">=75 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "2"}, {"groupId": "BG004", "value": "6"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "44"}, {"groupId": "BG001", "value": "52"}, {"groupId": "BG002", "value": "53"}, {"groupId": "BG003", "value": "48"}, {"groupId": "BG004", "value": "197"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "58"}, {"groupId": "BG001", "value": "54"}, {"groupId": "BG002", "value": "45"}, {"groupId": "BG003", "value": "47"}, {"groupId": "BG004", "value": "204"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "89"}, {"groupId": "BG001", "value": "93"}, {"groupId": "BG002", "value": "80"}, {"groupId": "BG003", "value": "79"}, {"groupId": "BG004", "value": "341"}]}]}, {"title": "Black/African American", "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "6"}, {"groupId": "BG003", "value": "6"}, {"groupId": "BG004", "value": "22"}]}]}, {"title": "Asian", "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "6"}, {"groupId": "BG003", "value": "3"}, {"groupId": "BG004", "value": "18"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "6"}, {"groupId": "BG003", "value": "7"}, {"groupId": "BG004", "value": "20"}]}]}, {"title": "Not Reported", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "Partcipants", "classes": [{"title": "Hispanic / Latino", "categories": [{"measurements": [{"groupId": "BG000", "value": "16"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "14"}, {"groupId": "BG003", "value": "15"}, {"groupId": "BG004", "value": "59"}]}]}, {"title": "Not Hispanic / Latino", "categories": [{"measurements": [{"groupId": "BG000", "value": "45"}, {"groupId": "BG001", "value": "49"}, {"groupId": "BG002", "value": "42"}, {"groupId": "BG003", "value": "38"}, {"groupId": "BG004", "value": "174"}]}]}, {"title": "Not Reported", "categories": [{"measurements": [{"groupId": "BG000", "value": "41"}, {"groupId": "BG001", "value": "43"}, {"groupId": "BG002", "value": "42"}, {"groupId": "BG003", "value": "42"}, {"groupId": "BG004", "value": "168"}]}]}]}, {"title": "Age Categorization, Female Only", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "=< 50 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "24"}, {"groupId": "BG002", "value": "22"}, {"groupId": "BG003", "value": "19"}, {"groupId": "BG004", "value": "82"}]}]}, {"title": "> 50 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "27"}, {"groupId": "BG001", "value": "28"}, {"groupId": "BG002", "value": "31"}, {"groupId": "BG003", "value": "29"}, {"groupId": "BG004", "value": "115"}]}]}]}, {"title": "Weight", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "92.10", "spread": "18.39"}, {"groupId": "BG001", "value": "91.09", "spread": "18.53"}, {"groupId": "BG002", "value": "89.30", "spread": "17.67"}, {"groupId": "BG003", "value": "86.56", "spread": "16.90"}, {"groupId": "BG004", "value": "89.84", "spread": "17.96"}]}]}]}, {"title": "Body Mass Index", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg/m^2", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "31.90", "spread": "4.82"}, {"groupId": "BG001", "value": "32.30", "spread": "4.53"}, {"groupId": "BG002", "value": "31.71", "spread": "4.71"}, {"groupId": "BG003", "value": "30.93", "spread": "4.26"}, {"groupId": "BG004", "value": "31.73", "spread": "4.60"}]}]}]}, {"title": "Body Mass Index Categorization", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "< 30", "categories": [{"measurements": [{"groupId": "BG000", "value": "36"}, {"groupId": "BG001", "value": "40"}, {"groupId": "BG002", "value": "35"}, {"groupId": "BG003", "value": "42"}, {"groupId": "BG004", "value": "153"}]}]}, {"title": ">= 30", "categories": [{"measurements": [{"groupId": "BG000", "value": "66"}, {"groupId": "BG001", "value": "66"}, {"groupId": "BG002", "value": "63"}, {"groupId": "BG003", "value": "53"}, {"groupId": "BG004", "value": "248"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Hemoglobin A1c (A1C) Changes From Baseline at Week 24", "description": "To compare the change from baseline in HbA1c achieved with each dose of saxagliptin versus placebo in treatment naive subjects with type 2 diabetes who have inadequate glycemic control defined as A1C \u22657.0% and \u226410.0%.", "populationDescription": "Randomized participants with both a baseline and post-baseline value (up to Week 24).", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Percentage of glycosylated hemoglobins", "timeFrame": "Baseline, Week 24", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline Mean", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.91", "spread": "0.09"}, {"groupId": "OG001", "value": "7.98", "spread": "0.11"}, {"groupId": "OG002", "value": "7.85", "spread": "0.09"}, {"groupId": "OG003", "value": "7.88", "spread": "0.10"}]}]}, {"title": "Adjusted Mean Change from Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.43", "spread": "0.10"}, {"groupId": "OG001", "value": "-0.46", "spread": "0.10"}, {"groupId": "OG002", "value": "-0.54", "spread": "0.10"}, {"groupId": "OG003", "value": "0.19", "spread": "0.10"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-0.62", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.90", "ciUpperLimit": "-0.33", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.14", "estimateComment": "ANCOVA model:post - pre = pre treatment"}, {"groupIds": ["OG001", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-0.64", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.93", "ciUpperLimit": "-0.36", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.14", "estimateComment": "ANCOVA model:post - pre = pre treatment"}, {"groupIds": ["OG002", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-0.73", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-1.02", "ciUpperLimit": "-0.44", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.15", "estimateComment": "ANCOVA model:post - pre = pre treatment"}]}, {"type": "SECONDARY", "title": "Baseline and Change From Baseline at Week 24 in Fasting Plasma Glucose (FPG)", "populationDescription": "Randomized participants with measure at given time points, Last Observation Carried Forward (LOCF).", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline, Week 24", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "101"}, {"groupId": "OG001", "value": "105"}, {"groupId": "OG002", "value": "97"}, {"groupId": "OG003", "value": "92"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "177.72", "spread": "4.12"}, {"groupId": "OG001", "value": "171.31", "spread": "4.09"}, {"groupId": "OG002", "value": "176.51", "spread": "4.43"}, {"groupId": "OG003", "value": "171.85", "spread": "4.80"}]}]}, {"title": "Adjusted Change from Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "-14.53", "spread": "3.82"}, {"groupId": "OG001", "value": "-8.67", "spread": "3.74"}, {"groupId": "OG002", "value": "-16.75", "spread": "3.89"}, {"groupId": "OG003", "value": "6.06", "spread": "4.00"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0002", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-20.60", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-31.47", "ciUpperLimit": "-9.72", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "5.53", "estimateComment": "ANCOVA model:post - pre = pre treatment"}, {"groupIds": ["OG001", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0074", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-14.73", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-25.50", "ciUpperLimit": "-3.97", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "5.48", "estimateComment": "ANCOVA model:post - pre = pre treatment"}, {"groupIds": ["OG002", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-22.81", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-33.79", "ciUpperLimit": "-11.84", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "5.58", "estimateComment": "ANCOVA model:post - pre = pre treatment"}]}, {"type": "SECONDARY", "title": "Percentage of Participants Achieving Therapeutic Glycemic Response (A1C < 7.0%) at Week 24", "populationDescription": "Randomized Participants with measurement at time point, Last Observation Carried Forward (LOCF)", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "Week 24", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "100"}, {"groupId": "OG001", "value": "103"}, {"groupId": "OG002", "value": "95"}, {"groupId": "OG003", "value": "92"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "35.0"}, {"groupId": "OG001", "value": "37.9"}, {"groupId": "OG002", "value": "41.1"}, {"groupId": "OG003", "value": "23.9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.1141", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "Fisher Exact", "statisticalComment": "The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.", "paramType": "Difference in Proportions", "paramValue": "11.1", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-3.1", "ciUpperLimit": "24.9"}, {"groupIds": ["OG001", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0443", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "Fisher Exact", "statisticalComment": "The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.", "paramType": "Difference in Proportions", "paramValue": "14.0", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.1", "ciUpperLimit": "27.6"}, {"groupIds": ["OG002", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0133", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "Fisher Exact", "statisticalComment": "The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.", "paramType": "Difference in Proportions", "paramValue": "17.1", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "2.8", "ciUpperLimit": "31.0"}]}, {"type": "SECONDARY", "title": "Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC)", "populationDescription": "Randomized participants with measure at given time points, Last Observation Carried Forward (LOCF).", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mg*min/dL", "timeFrame": "Baseline, Week 24", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "74"}, {"groupId": "OG001", "value": "79"}, {"groupId": "OG002", "value": "73"}, {"groupId": "OG003", "value": "66"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "45030", "spread": "1368.1"}, {"groupId": "OG001", "value": "45691", "spread": "1209.8"}, {"groupId": "OG002", "value": "44614", "spread": "1394.0"}, {"groupId": "OG003", "value": "46030", "spread": "1397.8"}]}]}, {"title": "Adjusted Change from Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "-6868", "spread": "1167.7"}, {"groupId": "OG001", "value": "-6896", "spread": "1130.2"}, {"groupId": "OG002", "value": "-8084", "spread": "1176.2"}, {"groupId": "OG003", "value": "-646.6", "spread": "1236.9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0003", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-6221", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-9570", "ciUpperLimit": "-2872", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1701.3", "estimateComment": "ANCOVA model:post - pre = pre treatment"}, {"groupIds": ["OG001", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0002", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-6249", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-9546", "ciUpperLimit": "-2952", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1675.1", "estimateComment": "ANCOVA model:post - pre = pre treatment"}, {"groupIds": ["OG002", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-7437", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-10798", "ciUpperLimit": "-4076", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1707.6", "estimateComment": "ANCOVA model:post - pre = pre treatment"}]}, {"type": "SECONDARY", "title": "Baseline and Change From Baseline at Week 24 in Fasting Plasma Glucose (FPG) - Open Label Cohort", "populationDescription": "Open Label Subjects with Measurement at Timepoint; Last Observation Carried Forward (LOCF)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline, Week 24", "groups": [{"id": "OG000", "title": "Open-Label Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "64"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "241.08", "spread": "6.19"}]}]}, {"title": "Change from Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "-33.42", "spread": "5.37"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Participants Achieving Therapeutic Glycemic Response (A1C < 7.0%) at Week 24 - Open Label Cohort", "populationDescription": "Open Label Participants with measurement at time point, Last Observation Carried Forward (LOCF)", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "Week 24", "groups": [{"id": "OG000", "title": "Open Label Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "64"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "14.1"}]}]}]}, {"type": "PRIMARY", "title": "A1C Changes From Baseline at Week 24 - Open Label Cohort", "description": "To compare the change from baseline in HbA1c achieved with each dose of saxagliptin versus placebo in treatment naive subjects with type 2 diabetes who have inadequate glycemic control defined as A1C \u22657.0% and \u226410.0%.", "populationDescription": "Open-label participants with both a baseline and a post-baseline (up to Week 24)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Percentage of glycosylated hemoglobins", "timeFrame": "Baseline, Week 24", "groups": [{"id": "OG000", "title": "Open Label Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "64"}]}], "classes": [{"title": "Baseline Mean", "categories": [{"measurements": [{"groupId": "OG000", "value": "10.70", "spread": "0.10"}]}]}, {"title": "Mean Change from Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.87", "spread": "0.18"}]}]}]}, {"type": "SECONDARY", "title": "Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC) - Open Label Cohort", "populationDescription": "Open Label participants with measure at given time points, Last Observation Carried Forward (LOCF).", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mg*min/dL", "timeFrame": "Baseline, Week 24", "groups": [{"id": "OG000", "title": "Open Label Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "64"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "60687", "spread": "2312.4"}]}]}, {"title": "Change from Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "-11078", "spread": "2132.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline Demographic Characteristic (Age, Continuous) - Summary for ST + LT Treatment Period - Open-Label Cohort", "description": "This cohort represents a different population (screening A1C \\> 10.0% and \u2264 12.0%) than the double-blind cohort, and was presented separately in the study report.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "years", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "49.09", "spread": "8.63"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline Demographic Characteristics - Summary for ST + LT Treatment Period - Open-Label Cohort", "description": "This cohort represents a different population (screening A1C \\> 10.0% and \u2264 12.0%) than the double-blind cohort, and was presented separately in the study report.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "classes": [{"title": "Age <65 years", "categories": [{"measurements": [{"groupId": "OG000", "value": "64"}]}]}, {"title": "Age >=65 years", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Age >=75 years", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Gender, Male", "categories": [{"measurements": [{"groupId": "OG000", "value": "32"}]}]}, {"title": "Gender, Female", "categories": [{"measurements": [{"groupId": "OG000", "value": "34"}]}]}, {"title": "Age =<50 years, females only", "categories": [{"measurements": [{"groupId": "OG000", "value": "19"}]}]}, {"title": "Age >50 years, females only", "categories": [{"measurements": [{"groupId": "OG000", "value": "15"}]}]}, {"title": "Race, White", "categories": [{"measurements": [{"groupId": "OG000", "value": "61"}]}]}, {"title": "Race, Black/African American", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}]}]}, {"title": "Race, Asian", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Race, Other", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Ethnicity, Hispanic/Latino", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}]}]}, {"title": "Ethnicity, Not Hispanic/Latino", "categories": [{"measurements": [{"groupId": "OG000", "value": "37"}]}]}, {"title": "Ethnicity, Not Reported", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}]}]}, {"title": "Body Mass Index <30%", "categories": [{"measurements": [{"groupId": "OG000", "value": "22"}]}]}, {"title": "Body Mass Index >=30%", "categories": [{"measurements": [{"groupId": "OG000", "value": "44"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline Demographic Characteristic (Weight) - Summary for ST + LT Treatment Period - Open-Label Cohort", "description": "This cohort represents a different population (screening A1C \\> 10.0% and \u2264 12.0%) than the double-blind cohort, and was presented separately in the study report.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "kg", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "91.41", "spread": "20.65"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline Demographic Characteristic (Body Mass Index) - Summary for ST + LT Treatment Period - Open-Label Cohort", "description": "This cohort represents a different population (screening A1C \\> 10.0% and \u2264 12.0%) than the double-blind cohort, and was presented separately in the study report.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "kg/m^2", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "31.73", "spread": "4.73"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Overall Summary of Adverse Events During ST+LT Treatment Period", "description": "AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "At Least 1 AE", "categories": [{"measurements": [{"groupId": "OG000", "value": "89"}, {"groupId": "OG001", "value": "94"}, {"groupId": "OG002", "value": "87"}, {"groupId": "OG003", "value": "77"}]}]}, {"title": "At Least 1 Related AE", "categories": [{"measurements": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "25"}, {"groupId": "OG003", "value": "25"}]}]}, {"title": "Deaths", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "At Least 1 SAE", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "18"}, {"groupId": "OG002", "value": "9"}, {"groupId": "OG003", "value": "11"}]}]}, {"title": "At Least 1 Related SAE", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Discontinuations Due to SAEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Discontinuations Due to AEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "10"}, {"groupId": "OG002", "value": "10"}, {"groupId": "OG003", "value": "5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Marked Laboratory Abnormalities - During ST + LT Treatment Period", "description": "A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: \\<0.9 x Pre-Rx \\& \\<=130mEq/L / high: \\>1.1 x Pre-Rx \\& \\>=150mEq/L; potassium, serum low: \\<=0.8 x Pre-Rx \\& \\>=6.0mEq/L / high: 1.2 x Pre-Rx \\& \\>=6.0mEq/L; LLN=lower limit of normal.", "populationDescription": "Number of Participants Analyzed=Treated participants; n=number of treated subjects with baseline value and at least one value during the ST + LT treatment period", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Hemoglobin < 8 g/dL (n=101, 105, 97, 93)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Hematocrit < 0.75 x pre-Rx (n=101, 105, 97, 93)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Platelets < 50 x 10^9 c/L (n=100, 104, 94, 93)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Platelets > 1.5 x ULN (n=100,104, 94, 93)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Leukocytes < 2 x 1000 c/\u00b5L (n=101, 105, 97, 93)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Neutrophils+Bands <1x1000 c/\u00b5L(n=101, 105, 97, 93)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Eosinophils >0.9x1000 c/\u00b5L (n=101, 105, 97, 93)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "5"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "4"}]}]}, {"title": "Lymphocytes <=0.75x1000 c/\u00b5L (n=101, 105, 97, 93)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "2"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "ALP >3 x pre-Rx and >ULN (n=101,105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "ALP >1.5 x ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "AST >3 x ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "AST >5 x ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "AST >10 x ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "AST >20 x ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "ALT >3 x ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "ALT >5 x ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "ALT >10 x ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "ALT >20 x ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Bilirubin Total >2mg/dL (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Bilirubin Total >1.5xULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Bilirubin Total >2xULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "BUN >2 x pre-Rx and >ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "3"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Creatinine >2.5 mg/dL (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Serum Fasting < 50 mg/dL (n=0, 0, 0, 0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Serum Fasting > 500 mg/dL (n=0, 0, 0, 0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Serum Unspec. < 50 mg/dL (n=0,0,0,0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Serum Unspec. > 500 mg/dL (n=0,0,0,0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Plasma Fasting<50mg/dL(n=101, 104, 96,94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "2"}]}]}, {"title": "Glucose,Plasma Fasting>500mg/dL(n=101, 104, 96,94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Plasma Unspec.<50mg/dL(n=102, 105, 98,95)", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "4"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "3"}]}]}, {"title": "Glucose,Plasma Unspec.>500mg/dL(n=102, 105, 98,95)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "2"}]}]}, {"title": "Sodium,Serum Low (see above) (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Sodium,Serum High(see above) (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Potassium,Serum Low(see above)(n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Potassium, Serum High(see above)(n=101,105,97,94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "3"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "3"}]}]}, {"title": "Chloride < 90 mEq/L (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Chloride > 120 mEq/L (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Albumin < 0.9 LLN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Creatine Kinase > 5 x ULN (n=101, 105, 97, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "4"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "4"}]}]}, {"title": "Uric Acid > 1.5 x ULN (n=0, 0, 0, 0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Protein Urine, >=2-4 (n=99, 103, 94, 92)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "3"}]}]}, {"title": "Blood Urine, >=2-4 (n=99, 103, 94, 92)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "11"}, {"groupId": "OG002", "value": "8"}, {"groupId": "OG003", "value": "16"}]}]}, {"title": "Red Blood Cells Urine >=2-4 (n=95, 97, 89, 88)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "8"}, {"groupId": "OG002", "value": "8"}, {"groupId": "OG003", "value": "14"}]}]}, {"title": "White Blood Cells Urine >=2-4 (n=95, 97, 89, 88)", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "19"}, {"groupId": "OG002", "value": "15"}, {"groupId": "OG003", "value": "12"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Hemoglobin During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "g/dL", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=102, 106, 98, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "14.49", "spread": "0.133"}, {"groupId": "OG001", "value": "14.45", "spread": "0.125"}, {"groupId": "OG002", "value": "14.47", "spread": "0.137"}, {"groupId": "OG003", "value": "14.50", "spread": "0.131"}]}]}, {"title": "Change from BL at Week 2 (n=95,100, 93, 87)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.21", "spread": "0.069"}, {"groupId": "OG001", "value": "-0.13", "spread": "0.065"}, {"groupId": "OG002", "value": "-0.22", "spread": "0.075"}, {"groupId": "OG003", "value": "-0.09", "spread": "0.078"}]}]}, {"title": "Change from BL at Week 4 (n=92, 99, 91, 91)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.16", "spread": "0.071"}, {"groupId": "OG001", "value": "-0.15", "spread": "0.082"}, {"groupId": "OG002", "value": "-0.09", "spread": "0.069"}, {"groupId": "OG003", "value": "0.10", "spread": "0.063"}]}]}, {"title": "Change from BL at Week 6 (n=91, 96, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.12", "spread": "0.069"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.074"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.073"}, {"groupId": "OG003", "value": "0.04", "spread": "0.069"}]}]}, {"title": "Change from BL at Week 8 (n=92, 90, 91, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.068"}, {"groupId": "OG001", "value": "0.04", "spread": "0.080"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.071"}, {"groupId": "OG003", "value": "0.09", "spread": "0.074"}]}]}, {"title": "Change from BL at Week 10 (n=70, 76, 69, 63)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.082"}, {"groupId": "OG001", "value": "-0.20", "spread": "0.096"}, {"groupId": "OG002", "value": "-0.13", "spread": "0.086"}, {"groupId": "OG003", "value": "0.04", "spread": "0.097"}]}]}, {"title": "Change from BL at Week 12 (n=85, 88, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.074"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.079"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.083"}, {"groupId": "OG003", "value": "0.16", "spread": "0.075"}]}]}, {"title": "Change from BL at Week 14 (n=76, 80, 81, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.09", "spread": "0.090"}, {"groupId": "OG001", "value": "-0.05", "spread": "0.078"}, {"groupId": "OG002", "value": "-0.12", "spread": "0.085"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.083"}]}]}, {"title": "Change from BL at Week 16 (n=90, 91, 83, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.10", "spread": "0.087"}, {"groupId": "OG001", "value": "0.01", "spread": "0.078"}, {"groupId": "OG002", "value": "0.00", "spread": "0.087"}, {"groupId": "OG003", "value": "0.04", "spread": "0.084"}]}]}, {"title": "Change from BL at Week 18 (n=78, 75, 82, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.26", "spread": "0.083"}, {"groupId": "OG001", "value": "-0.10", "spread": "0.079"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.092"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.099"}]}]}, {"title": "Change from BL at Week 20 (n=83, 80, 78, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.16", "spread": "0.079"}, {"groupId": "OG001", "value": "-0.14", "spread": "0.093"}, {"groupId": "OG002", "value": "-0.25", "spread": "0.081"}, {"groupId": "OG003", "value": "-0.19", "spread": "0.086"}]}]}, {"title": "Change from BL at Week 22 (n=78, 74, 76, 65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.35", "spread": "0.075"}, {"groupId": "OG001", "value": "-0.23", "spread": "0.092"}, {"groupId": "OG002", "value": "-0.36", "spread": "0.087"}, {"groupId": "OG003", "value": "-0.18", "spread": "0.102"}]}]}, {"title": "Change from BL at Week 24 (n=83, 82, 78, 74)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.37", "spread": "0.079"}, {"groupId": "OG001", "value": "-0.25", "spread": "0.080"}, {"groupId": "OG002", "value": "-0.32", "spread": "0.078"}, {"groupId": "OG003", "value": "-0.14", "spread": "0.100"}]}]}, {"title": "Change from BL at Week 30 (n=77, 78, 79, 67)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.25", "spread": "0.081"}, {"groupId": "OG001", "value": "-0.29", "spread": "0.097"}, {"groupId": "OG002", "value": "-0.19", "spread": "0.086"}, {"groupId": "OG003", "value": "-0.18", "spread": "0.101"}]}]}, {"title": "Change from BL at Week 37 (n=75, 73, 70, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.31", "spread": "0.094"}, {"groupId": "OG001", "value": "-0.22", "spread": "0.087"}, {"groupId": "OG002", "value": "-0.06", "spread": "0.090"}, {"groupId": "OG003", "value": "-0.33", "spread": "0.093"}]}]}, {"title": "Change from BL at Week 50 (n=67, 71, 71, 61)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.17", "spread": "0.082"}, {"groupId": "OG001", "value": "0.06", "spread": "0.103"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.107"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.100"}]}]}, {"title": "Change from BL at Week 63 (n=61, 66, 67, 55)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.18", "spread": "0.112"}, {"groupId": "OG001", "value": "-0.11", "spread": "0.096"}, {"groupId": "OG002", "value": "0.07", "spread": "0.102"}, {"groupId": "OG003", "value": "0.08", "spread": "0.139"}]}]}, {"title": "Change from BL at Week 76 (n=51, 59, 63, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.27", "spread": "0.125"}, {"groupId": "OG001", "value": "-0.19", "spread": "0.119"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.102"}, {"groupId": "OG003", "value": "-0.10", "spread": "0.117"}]}]}, {"title": "Change from BL at Week 89 (n=49, 58, 56, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.18", "spread": "0.109"}, {"groupId": "OG001", "value": "-0.09", "spread": "0.097"}, {"groupId": "OG002", "value": "-0.04", "spread": "0.103"}, {"groupId": "OG003", "value": "-0.10", "spread": "0.109"}]}]}, {"title": "Change from BL at Week 102 (n=40, 49, 51, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.32", "spread": "0.132"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.129"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.121"}, {"groupId": "OG003", "value": "-0.29", "spread": "0.131"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 43, 35)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.41", "spread": "0.132"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.137"}, {"groupId": "OG002", "value": "-0.18", "spread": "0.147"}, {"groupId": "OG003", "value": "-0.19", "spread": "0.116"}]}]}, {"title": "Change from BL at Week 128 (n=30, 40, 40, 30)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.38", "spread": "0.125"}, {"groupId": "OG001", "value": "-0.17", "spread": "0.128"}, {"groupId": "OG002", "value": "-0.25", "spread": "0.132"}, {"groupId": "OG003", "value": "-0.33", "spread": "0.124"}]}]}, {"title": "Change from BL at Week 141 (n=28, 39, 34, 28)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.40", "spread": "0.125"}, {"groupId": "OG001", "value": "-0.35", "spread": "0.156"}, {"groupId": "OG002", "value": "-0.15", "spread": "0.169"}, {"groupId": "OG003", "value": "-0.36", "spread": "0.104"}]}]}, {"title": "Change from BL at Week 154 (n=26, 34, 31, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.45", "spread": "0.160"}, {"groupId": "OG001", "value": "-0.37", "spread": "0.186"}, {"groupId": "OG002", "value": "-0.24", "spread": "0.166"}, {"groupId": "OG003", "value": "-0.25", "spread": "0.130"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.51", "spread": "0.178"}, {"groupId": "OG001", "value": "-0.05", "spread": "0.161"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.170"}, {"groupId": "OG003", "value": "-0.24", "spread": "0.148"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.38", "spread": "0.178"}, {"groupId": "OG001", "value": "-0.08", "spread": "0.176"}, {"groupId": "OG002", "value": "-0.08", "spread": "0.167"}, {"groupId": "OG003", "value": "-0.61", "spread": "0.169"}]}]}, {"title": "Change from BL at Week 193 (n=19, 26, 26, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.45", "spread": "0.212"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.190"}, {"groupId": "OG002", "value": "-0.16", "spread": "0.178"}, {"groupId": "OG003", "value": "-0.39", "spread": "0.175"}]}]}, {"title": "Change from BL at Week 206 (n=17, 22, 24, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.51", "spread": "0.221"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.195"}, {"groupId": "OG002", "value": "0.10", "spread": "0.124"}, {"groupId": "OG003", "value": "-0.32", "spread": "0.174"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Hematocrit During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage red blood cells", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=102, 106, 98, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "42.5", "spread": "0.35"}, {"groupId": "OG001", "value": "42.8", "spread": "0.35"}, {"groupId": "OG002", "value": "42.7", "spread": "0.37"}, {"groupId": "OG003", "value": "42.8", "spread": "0.35"}]}]}, {"title": "Change from BL at Week 2 (n=95,100, 93, 87)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "0.22"}, {"groupId": "OG001", "value": "-0.2", "spread": "0.20"}, {"groupId": "OG002", "value": "-0.7", "spread": "0.21"}, {"groupId": "OG003", "value": "-0.4", "spread": "0.23"}]}]}, {"title": "Change from BL at Week 4 (n=92, 99, 91, 91)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.21"}, {"groupId": "OG001", "value": "-0.2", "spread": "0.24"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.22"}, {"groupId": "OG003", "value": "0.3", "spread": "0.21"}]}]}, {"title": "Change from BL at Week 6 (n=91, 96, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.19"}, {"groupId": "OG001", "value": "0.3", "spread": "0.24"}, {"groupId": "OG002", "value": "0.0", "spread": "0.24"}, {"groupId": "OG003", "value": "0.3", "spread": "0.25"}]}]}, {"title": "Change from BL at Week 8 (n=92, 90, 91, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.5", "spread": "0.22"}, {"groupId": "OG001", "value": "0.4", "spread": "0.27"}, {"groupId": "OG002", "value": "0.2", "spread": "0.20"}, {"groupId": "OG003", "value": "0.5", "spread": "0.25"}]}]}, {"title": "Change from BL at Week 10 (n=70, 76, 69, 63)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.6", "spread": "0.25"}, {"groupId": "OG001", "value": "-0.0", "spread": "0.31"}, {"groupId": "OG002", "value": "-0.2", "spread": "0.24"}, {"groupId": "OG003", "value": "0.5", "spread": "0.32"}]}]}, {"title": "Change from BL at Week 12 (n=85, 88, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.6", "spread": "0.25"}, {"groupId": "OG001", "value": "0.4", "spread": "0.26"}, {"groupId": "OG002", "value": "0.6", "spread": "0.26"}, {"groupId": "OG003", "value": "0.7", "spread": "0.25"}]}]}, {"title": "Change from BL at Week 14 (n=76, 80, 81, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.6", "spread": "0.27"}, {"groupId": "OG001", "value": "0.6", "spread": "0.27"}, {"groupId": "OG002", "value": "0.2", "spread": "0.27"}, {"groupId": "OG003", "value": "0.2", "spread": "0.26"}]}]}, {"title": "Change from BL at Week 16 (n=90. 91, 83, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.5", "spread": "0.24"}, {"groupId": "OG001", "value": "0.7", "spread": "0.26"}, {"groupId": "OG002", "value": "0.6", "spread": "0.25"}, {"groupId": "OG003", "value": "0.3", "spread": "0.30"}]}]}, {"title": "Change from BL at Week 18 (n=78, 75, 82, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2", "spread": "0.27"}, {"groupId": "OG001", "value": "0.4", "spread": "0.29"}, {"groupId": "OG002", "value": "0.3", "spread": "0.24"}, {"groupId": "OG003", "value": "0.4", "spread": "0.30"}]}]}, {"title": "Change from BL at Week 20 (n=83, 80, 78, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7", "spread": "0.25"}, {"groupId": "OG001", "value": "0.4", "spread": "0.31"}, {"groupId": "OG002", "value": "0.1", "spread": "0.26"}, {"groupId": "OG003", "value": "0.2", "spread": "0.27"}]}]}, {"title": "Change from BL at Week 22 (n=78, 74, 76, 65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "0.27"}, {"groupId": "OG001", "value": "0.2", "spread": "0.32"}, {"groupId": "OG002", "value": "-0.3", "spread": "0.26"}, {"groupId": "OG003", "value": "0.5", "spread": "0.32"}]}]}, {"title": "Change from BL at Week 24 (n=83, 82, 78, 74)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0", "spread": "0.24"}, {"groupId": "OG001", "value": "0.2", "spread": "0.28"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.24"}, {"groupId": "OG003", "value": "0.5", "spread": "0.32"}]}]}, {"title": "Change from BL at Week 30 (n=77, 78, 79, 67)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.5", "spread": "0.30"}, {"groupId": "OG001", "value": "-0.1", "spread": "0.36"}, {"groupId": "OG002", "value": "0.2", "spread": "0.30"}, {"groupId": "OG003", "value": "0.4", "spread": "0.35"}]}]}, {"title": "Change from BL at Week 37 (n=75, 73, 70, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0", "spread": "0.30"}, {"groupId": "OG001", "value": "-0.1", "spread": "0.27"}, {"groupId": "OG002", "value": "0.4", "spread": "0.29"}, {"groupId": "OG003", "value": "-0.4", "spread": "0.33"}]}]}, {"title": "Change from BL at Week 50 (n=67, 71, 71, 61)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.29"}, {"groupId": "OG001", "value": "0.3", "spread": "0.33"}, {"groupId": "OG002", "value": "0.1", "spread": "0.34"}, {"groupId": "OG003", "value": "0.2", "spread": "0.27"}]}]}, {"title": "Change from BL at Week 63 (n=61, 66, 67, 55)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "0.34"}, {"groupId": "OG001", "value": "0.1", "spread": "0.31"}, {"groupId": "OG002", "value": "0.6", "spread": "0.34"}, {"groupId": "OG003", "value": "0.7", "spread": "0.43"}]}]}, {"title": "Change from BL at Week 76 (n=51, 59, 63, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7", "spread": "0.39"}, {"groupId": "OG001", "value": "0.5", "spread": "0.40"}, {"groupId": "OG002", "value": "0.7", "spread": "0.35"}, {"groupId": "OG003", "value": "0.8", "spread": "0.34"}]}]}, {"title": "Change from BL at Week 89 (n=49, 58, 56, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.9", "spread": "0.37"}, {"groupId": "OG001", "value": "0.9", "spread": "0.34"}, {"groupId": "OG002", "value": "1.2", "spread": "0.35"}, {"groupId": "OG003", "value": "0.4", "spread": "0.36"}]}]}, {"title": "Change from BL at Week 102 (n=40, 49, 51, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.37"}, {"groupId": "OG001", "value": "0.5", "spread": "0.40"}, {"groupId": "OG002", "value": "-0.0", "spread": "0.34"}, {"groupId": "OG003", "value": "-0.7", "spread": "0.36"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 43, 35)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.0", "spread": "0.42"}, {"groupId": "OG001", "value": "0.6", "spread": "0.42"}, {"groupId": "OG002", "value": "0.2", "spread": "0.46"}, {"groupId": "OG003", "value": "0.2", "spread": "0.40"}]}]}, {"title": "Change from BL at Week 128 (n=30, 40, 40, 30)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2", "spread": "0.42"}, {"groupId": "OG001", "value": "0.3", "spread": "0.43"}, {"groupId": "OG002", "value": "0.0", "spread": "0.43"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.42"}]}]}, {"title": "Change from BL at Week 141 (n=28, 39, 34, 28)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.42"}, {"groupId": "OG001", "value": "-0.1", "spread": "0.48"}, {"groupId": "OG002", "value": "0.2", "spread": "0.50"}, {"groupId": "OG003", "value": "-0.2", "spread": "0.41"}]}]}, {"title": "Change from BL at Week 154 (n=26, 34, 31, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "0.45"}, {"groupId": "OG001", "value": "-0.8", "spread": "0.43"}, {"groupId": "OG002", "value": "-1.0", "spread": "0.51"}, {"groupId": "OG003", "value": "-0.3", "spread": "0.43"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.53"}, {"groupId": "OG001", "value": "0.2", "spread": "0.46"}, {"groupId": "OG002", "value": "0.2", "spread": "0.56"}, {"groupId": "OG003", "value": "-0.4", "spread": "0.48"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.1", "spread": "0.55"}, {"groupId": "OG001", "value": "0.6", "spread": "0.58"}, {"groupId": "OG002", "value": "1.0", "spread": "0.53"}, {"groupId": "OG003", "value": "-0.5", "spread": "0.57"}]}]}, {"title": "Change from BL at Week 193 (n=19, 26, 26, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.6", "spread": "0.65"}, {"groupId": "OG001", "value": "1.1", "spread": "0.55"}, {"groupId": "OG002", "value": "0.5", "spread": "0.61"}, {"groupId": "OG003", "value": "-0.0", "spread": "0.59"}]}]}, {"title": "Change from BL at Week 206 (n=17, 22, 24, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "0.54"}, {"groupId": "OG001", "value": "0.2", "spread": "0.52"}, {"groupId": "OG002", "value": "0.2", "spread": "0.42"}, {"groupId": "OG003", "value": "-0.5", "spread": "0.52"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Red Blood Cell Counts (x 10^6 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "x 10^6 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=102, 106, 98, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.80", "spread": "0.038"}, {"groupId": "OG001", "value": "4.80", "spread": "0.042"}, {"groupId": "OG002", "value": "4.82", "spread": "0.039"}, {"groupId": "OG003", "value": "4.82", "spread": "0.043"}]}]}, {"title": "Change from BL at Week 2 (n=95,100, 93, 87", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.06", "spread": "0.021"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.021"}, {"groupId": "OG002", "value": "-0.08", "spread": "0.023"}, {"groupId": "OG003", "value": "-0.05", "spread": "0.023"}]}]}, {"title": "Change from BL at Week 4 (n=92, 99, 91, 91)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.023"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.026"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.022"}, {"groupId": "OG003", "value": "0.04", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 6 (n=91, 96, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.022"}, {"groupId": "OG001", "value": "0.02", "spread": "0.024"}, {"groupId": "OG002", "value": "0.00", "spread": "0.026"}, {"groupId": "OG003", "value": "0.02", "spread": "0.023"}]}]}, {"title": "Change from BL at Week 8 (n=92, 90, 91, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.020"}, {"groupId": "OG001", "value": "0.03", "spread": "0.026"}, {"groupId": "OG002", "value": "0.03", "spread": "0.023"}, {"groupId": "OG003", "value": "0.05", "spread": "0.023"}]}]}, {"title": "Change from BL at Week 10 (n=70, 76, 69, 63)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.026"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.033"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.026"}, {"groupId": "OG003", "value": "0.07", "spread": "0.032"}]}]}, {"title": "Change from BL at Week 12 (n=85, 88, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.025"}, {"groupId": "OG001", "value": "0.03", "spread": "0.029"}, {"groupId": "OG002", "value": "0.07", "spread": "0.025"}, {"groupId": "OG003", "value": "0.08", "spread": "0.026"}]}]}, {"title": "Change from BL at Week 14 (n=76, 80, 81, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.027"}, {"groupId": "OG001", "value": "0.03", "spread": "0.029"}, {"groupId": "OG002", "value": "0.04", "spread": "0.030"}, {"groupId": "OG003", "value": "0.04", "spread": "0.025"}]}]}, {"title": "Change from BL at Week 16 (n=90, 91, 83, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.027"}, {"groupId": "OG001", "value": "0.08", "spread": "0.028"}, {"groupId": "OG002", "value": "0.08", "spread": "0.027"}, {"groupId": "OG003", "value": "0.06", "spread": "0.028"}]}]}, {"title": "Change from BL at Week 18 (n=78, 75, 82, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.024"}, {"groupId": "OG001", "value": "0.04", "spread": "0.029"}, {"groupId": "OG002", "value": "0.05", "spread": "0.028"}, {"groupId": "OG003", "value": "0.04", "spread": "0.030"}]}]}, {"title": "Change from BL at Week 20 (n=83, 80, 78, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.023"}, {"groupId": "OG001", "value": "0.02", "spread": "0.031"}, {"groupId": "OG002", "value": "0.01", "spread": "0.025"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.026"}]}]}, {"title": "Change from BL at Week 22 (n=78, 74, 76, 65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.023"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.033"}, {"groupId": "OG002", "value": "-0.05", "spread": "0.029"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.032"}]}]}, {"title": "Change from BL at Week 24 (n=83, 82, 78, 74)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.024"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.029"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.026"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.031"}]}]}, {"title": "Change from BL at Week 30 (n=77, 78, 79, 67)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.027"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.035"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.031"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.034"}]}]}, {"title": "Change from BL at Week 37 (n=75, 73, 70, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.028"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.027"}, {"groupId": "OG002", "value": "0.04", "spread": "0.031"}, {"groupId": "OG003", "value": "-0.09", "spread": "0.033"}]}]}, {"title": "Change from BL at Week 50 (n=67, 71, 71, 61)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.027"}, {"groupId": "OG001", "value": "0.04", "spread": "0.031"}, {"groupId": "OG002", "value": "0.02", "spread": "0.034"}, {"groupId": "OG003", "value": "0.01", "spread": "0.026"}]}]}, {"title": "Change from BL at Week 63 (n=61, 66, 67, 55)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.032"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.028"}, {"groupId": "OG002", "value": "0.08", "spread": "0.034"}, {"groupId": "OG003", "value": "0.05", "spread": "0.045"}]}]}, {"title": "Change from BL at Week 76 (n=51, 59, 63, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.07", "spread": "0.037"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.038"}, {"groupId": "OG002", "value": "0.00", "spread": "0.036"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.037"}]}]}, {"title": "Change from BL at Week 89 (n=49, 58, 56, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.034"}, {"groupId": "OG001", "value": "-0.06", "spread": "0.028"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.035"}, {"groupId": "OG003", "value": "-0.07", "spread": "0.031"}]}]}, {"title": "Change from BL at Week 102 (n=40, 49, 51, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.10", "spread": "0.040"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.043"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.037"}, {"groupId": "OG003", "value": "-0.13", "spread": "0.037"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 43, 35)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.039"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.043"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.044"}, {"groupId": "OG003", "value": "-0.06", "spread": "0.033"}]}]}, {"title": "Change from BL at Week 128 (n=30, 40, 40, 30)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.05", "spread": "0.037"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.039"}, {"groupId": "OG002", "value": "-0.04", "spread": "0.048"}, {"groupId": "OG003", "value": "-0.10", "spread": "0.039"}]}]}, {"title": "Change from BL at Week 141 (n=28, 39, 34, 28)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.10", "spread": "0.037"}, {"groupId": "OG001", "value": "-0.13", "spread": "0.048"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.052"}, {"groupId": "OG003", "value": "-0.11", "spread": "0.041"}]}]}, {"title": "Change from BL at Week 154 (n=26, 35, 31, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.13", "spread": "0.037"}, {"groupId": "OG001", "value": "-0.13", "spread": "0.045"}, {"groupId": "OG002", "value": "-0.08", "spread": "0.054"}, {"groupId": "OG003", "value": "-0.09", "spread": "0.045"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.11", "spread": "0.052"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.049"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.057"}, {"groupId": "OG003", "value": "-0.10", "spread": "0.044"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.05", "spread": "0.041"}, {"groupId": "OG001", "value": "-0.08", "spread": "0.059"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.054"}, {"groupId": "OG003", "value": "-0.17", "spread": "0.056"}]}]}, {"title": "Change from BL at Week 193 (n=19, 26, 26, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.05", "spread": "0.054"}, {"groupId": "OG001", "value": "-0.06", "spread": "0.061"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.057"}, {"groupId": "OG003", "value": "-0.10", "spread": "0.062"}]}]}, {"title": "Change from BL at Week 206 (n=17, 22, 24, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.064"}, {"groupId": "OG001", "value": "-0.06", "spread": "0.058"}, {"groupId": "OG002", "value": "0.06", "spread": "0.043"}, {"groupId": "OG003", "value": "-0.08", "spread": "0.055"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Platelet Counts (x 10^9 c/L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "x 10^9 c/L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=101, 106, 96, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "251.1", "spread": "6.33"}, {"groupId": "OG001", "value": "253.1", "spread": "5.93"}, {"groupId": "OG002", "value": "261.6", "spread": "6.71"}, {"groupId": "OG003", "value": "259.8", "spread": "6.25"}]}]}, {"title": "Change from BL at Week 2 (n=92, 96, 85, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.8", "spread": "3.40"}, {"groupId": "OG001", "value": "4.4", "spread": "2.82"}, {"groupId": "OG002", "value": "2.2", "spread": "3.72"}, {"groupId": "OG003", "value": "9.5", "spread": "3.47"}]}]}, {"title": "Change from BL at Week 4 (n=88, 97, 90, 90)", "categories": [{"measurements": [{"groupId": "OG000", "value": "11.2", "spread": "3.39"}, {"groupId": "OG001", "value": "8.6", "spread": "3.41"}, {"groupId": "OG002", "value": "5.6", "spread": "3.11"}, {"groupId": "OG003", "value": "11.3", "spread": "2.94"}]}]}, {"title": "Change from BL at Week 6 (n=88, 93, 84, 81)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.3", "spread": "2.85"}, {"groupId": "OG001", "value": "4.3", "spread": "3.53"}, {"groupId": "OG002", "value": "-0.2", "spread": "3.39"}, {"groupId": "OG003", "value": "9.5", "spread": "3.05"}]}]}, {"title": "Change from BL at Week 8 (n=86, 85, 86, 77)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4", "spread": "3.21"}, {"groupId": "OG001", "value": "1.0", "spread": "3.13"}, {"groupId": "OG002", "value": "-4.3", "spread": "2.94"}, {"groupId": "OG003", "value": "4.0", "spread": "4.26"}]}]}, {"title": "Change from BL at Week 10 (n=68, 75, 67, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "3.87"}, {"groupId": "OG001", "value": "3.0", "spread": "3.99"}, {"groupId": "OG002", "value": "-4.4", "spread": "4.44"}, {"groupId": "OG003", "value": "7.1", "spread": "3.53"}]}]}, {"title": "Change from BL at Week 12 (n=83, 84, 85, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-6.3", "spread": "3.58"}, {"groupId": "OG001", "value": "-1.3", "spread": "3.85"}, {"groupId": "OG002", "value": "-4.8", "spread": "4.14"}, {"groupId": "OG003", "value": "4.0", "spread": "3.21"}]}]}, {"title": "Change from BL at Week 14 (n=72, 79, 77, 74)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "3.91"}, {"groupId": "OG001", "value": "3.2", "spread": "4.75"}, {"groupId": "OG002", "value": "-3.7", "spread": "4.21"}, {"groupId": "OG003", "value": "5.2", "spread": "3.59"}]}]}, {"title": "Change from BL at Week 16 (n=86, 88, 81, 69)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.3", "spread": "3.73"}, {"groupId": "OG001", "value": "1.1", "spread": "3.66"}, {"groupId": "OG002", "value": "-6.0", "spread": "3.74"}, {"groupId": "OG003", "value": "3.2", "spread": "3.72"}]}]}, {"title": "Change from BL at Week 18 (n=77, 71, 79, 70)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.1", "spread": "3.93"}, {"groupId": "OG001", "value": "2.0", "spread": "4.06"}, {"groupId": "OG002", "value": "-2.7", "spread": "3.63"}, {"groupId": "OG003", "value": "5.8", "spread": "3.79"}]}]}, {"title": "Change from BL at Week 20 (n=78, 78, 72, 70)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.9", "spread": "3.87"}, {"groupId": "OG001", "value": "-4.8", "spread": "4.39"}, {"groupId": "OG002", "value": "-8.3", "spread": "3.94"}, {"groupId": "OG003", "value": "-1.3", "spread": "3.38"}]}]}, {"title": "Change from BL at Week 22 (n=74, 72, 73, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "4.64"}, {"groupId": "OG001", "value": "-2.5", "spread": "3.91"}, {"groupId": "OG002", "value": "-5.4", "spread": "4.01"}, {"groupId": "OG003", "value": "5.0", "spread": "3.48"}]}]}, {"title": "Change from BL at Week 24 (n=80, 76, 73, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-7.1", "spread": "3.94"}, {"groupId": "OG001", "value": "-6.0", "spread": "4.00"}, {"groupId": "OG002", "value": "-15.5", "spread": "4.54"}, {"groupId": "OG003", "value": "-3.0", "spread": "3.66"}]}]}, {"title": "Change from BL at Week 30 (n=73, 74, 74, 67)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "5.66"}, {"groupId": "OG001", "value": "-3.3", "spread": "4.37"}, {"groupId": "OG002", "value": "-9.9", "spread": "4.34"}, {"groupId": "OG003", "value": "4.5", "spread": "4.08"}]}]}, {"title": "Change from BL at Week 37 (n=70, 68, 66, 59)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-14.3", "spread": "3.85"}, {"groupId": "OG001", "value": "-8.1", "spread": "4.71"}, {"groupId": "OG002", "value": "-15.6", "spread": "3.93"}, {"groupId": "OG003", "value": "0.1", "spread": "4.81"}]}]}, {"title": "Change from BL at Week 50 (n=66, 67, 66, 59)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.5", "spread": "4.25"}, {"groupId": "OG001", "value": "-5.6", "spread": "4.39"}, {"groupId": "OG002", "value": "-11.5", "spread": "3.76"}, {"groupId": "OG003", "value": "6.6", "spread": "6.29"}]}]}, {"title": "Change from BL at Week 63 (n=59, 64, 65, 54)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.1", "spread": "4.57"}, {"groupId": "OG001", "value": "-3.4", "spread": "4.24"}, {"groupId": "OG002", "value": "-6.3", "spread": "4.23"}, {"groupId": "OG003", "value": "10.2", "spread": "5.37"}]}]}, {"title": "Change from BL at Week 76 (n=50, 58, 61, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "5.64"}, {"groupId": "OG001", "value": "-1.5", "spread": "4.56"}, {"groupId": "OG002", "value": "-6.0", "spread": "3.68"}, {"groupId": "OG003", "value": "1.2", "spread": "4.88"}]}]}, {"title": "Change from BL at Week 89 (n=47, 56, 54, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.5", "spread": "5.29"}, {"groupId": "OG001", "value": "1.9", "spread": "5.02"}, {"groupId": "OG002", "value": "-6.7", "spread": "3.83"}, {"groupId": "OG003", "value": "2.7", "spread": "4.97"}]}]}, {"title": "Change from BL at Week 102 (n=39, 47, 49, 39)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.2", "spread": "7.75"}, {"groupId": "OG001", "value": "-2.3", "spread": "5.34"}, {"groupId": "OG002", "value": "-4.8", "spread": "3.65"}, {"groupId": "OG003", "value": "9.7", "spread": "7.21"}]}]}, {"title": "Change from BL at Week 115 (n=33, 41, 41, 34)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.0", "spread": "8.04"}, {"groupId": "OG001", "value": "-8.8", "spread": "4.96"}, {"groupId": "OG002", "value": "-12.0", "spread": "4.23"}, {"groupId": "OG003", "value": "9.2", "spread": "7.57"}]}]}, {"title": "Change from BL at Week 128 (n=30, 38, 39, 30)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.8", "spread": "5.74"}, {"groupId": "OG001", "value": "-2.1", "spread": "5.39"}, {"groupId": "OG002", "value": "-2.6", "spread": "5.04"}, {"groupId": "OG003", "value": "2.6", "spread": "7.91"}]}]}, {"title": "Change from BL at Week 141 (n=27, 39, 33, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.1", "spread": "5.34"}, {"groupId": "OG001", "value": "-4.6", "spread": "5.16"}, {"groupId": "OG002", "value": "-0.3", "spread": "4.73"}, {"groupId": "OG003", "value": "-1.3", "spread": "8.24"}]}]}, {"title": "Change from BL at Week 154 (n=25, 35, 31, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.0", "spread": "6.95"}, {"groupId": "OG001", "value": "5.8", "spread": "7.20"}, {"groupId": "OG002", "value": "-2.9", "spread": "5.25"}, {"groupId": "OG003", "value": "8.8", "spread": "13.59"}]}]}, {"title": "Change from BL at Week 167 (n=22, 32, 28, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-18.0", "spread": "6.71"}, {"groupId": "OG001", "value": "-0.1", "spread": "6.99"}, {"groupId": "OG002", "value": "-14.6", "spread": "6.21"}, {"groupId": "OG003", "value": "4.3", "spread": "8.63"}]}]}, {"title": "Change from BL at Week 180 (n=20, 27, 27, 25)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-11.1", "spread": "6.57"}, {"groupId": "OG001", "value": "-24.0", "spread": "6.18"}, {"groupId": "OG002", "value": "-17.3", "spread": "6.54"}, {"groupId": "OG003", "value": "4.0", "spread": "10.72"}]}]}, {"title": "Change from BL at Week 193 (n=17, 25, 25, 22)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-13.6", "spread": "8.11"}, {"groupId": "OG001", "value": "-13.4", "spread": "9.58"}, {"groupId": "OG002", "value": "-13.4", "spread": "6.00"}, {"groupId": "OG003", "value": "-12.0", "spread": "7.27"}]}]}, {"title": "Change from BL at Week 206 (n=15, 21, 23, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.6", "spread": "10.45"}, {"groupId": "OG001", "value": "-18.7", "spread": "9.01"}, {"groupId": "OG002", "value": "6.2", "spread": "9.35"}, {"groupId": "OG003", "value": "-6.1", "spread": "11.49"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in White Blood Cell Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "x 10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=102, 106, 98, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.71", "spread": "0.179"}, {"groupId": "OG001", "value": "6.75", "spread": "0.198"}, {"groupId": "OG002", "value": "6.82", "spread": "0.155"}, {"groupId": "OG003", "value": "6.79", "spread": "0.182"}]}]}, {"title": "Change from BL at Week 2 (n=95, 99, 92, 86)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.11", "spread": "0.136"}, {"groupId": "OG001", "value": "0.05", "spread": "0.132"}, {"groupId": "OG002", "value": "-0.14", "spread": "0.113"}, {"groupId": "OG003", "value": "-0.23", "spread": "0.156"}]}]}, {"title": "Change from BL at Week 4 (n=92, 99, 90, 90)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.132"}, {"groupId": "OG001", "value": "0.05", "spread": "0.125"}, {"groupId": "OG002", "value": "-0.16", "spread": "0.132"}, {"groupId": "OG003", "value": "0.17", "spread": "0.137"}]}]}, {"title": "Change from BL at Week 6 (n=89, 95, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.115"}, {"groupId": "OG001", "value": "0.10", "spread": "0.126"}, {"groupId": "OG002", "value": "-0.18", "spread": "0.128"}, {"groupId": "OG003", "value": "0.09", "spread": "0.172"}]}]}, {"title": "Change from BL at Week 8 (n=91, 89, 90, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.132"}, {"groupId": "OG001", "value": "0.18", "spread": "0.144"}, {"groupId": "OG002", "value": "-0.17", "spread": "0.121"}, {"groupId": "OG003", "value": "0.16", "spread": "0.149"}]}]}, {"title": "Change from BL at Week 10 (n=68, 76, 69, 63)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.32", "spread": "0.168"}, {"groupId": "OG001", "value": "0.55", "spread": "0.169"}, {"groupId": "OG002", "value": "0.12", "spread": "0.162"}, {"groupId": "OG003", "value": "0.53", "spread": "0.208"}]}]}, {"title": "Change from BL at Week 12 (n=83, 88, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.148"}, {"groupId": "OG001", "value": "0.09", "spread": "0.155"}, {"groupId": "OG002", "value": "0.05", "spread": "0.145"}, {"groupId": "OG003", "value": "0.26", "spread": "0.163"}]}]}, {"title": "Change from BL at Week 14 (n=76, 78, 80, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.33", "spread": "0.196"}, {"groupId": "OG001", "value": "0.71", "spread": "0.166"}, {"groupId": "OG002", "value": "0.22", "spread": "0.134"}, {"groupId": "OG003", "value": "0.56", "spread": "0.192"}]}]}, {"title": "Change from BL at Week 16 (n=90, 91, 83, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.24", "spread": "0.146"}, {"groupId": "OG001", "value": "0.54", "spread": "0.148"}, {"groupId": "OG002", "value": "0.04", "spread": "0.138"}, {"groupId": "OG003", "value": "0.19", "spread": "0.163"}]}]}, {"title": "Change from BL at Week 18 (n=78, 75, 82, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.37", "spread": "0.166"}, {"groupId": "OG001", "value": "0.82", "spread": "0.172"}, {"groupId": "OG002", "value": "0.42", "spread": "0.142"}, {"groupId": "OG003", "value": "0.32", "spread": "0.185"}]}]}, {"title": "Change from BL at Week 20 (n=83, 79, 78, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.29", "spread": "0.150"}, {"groupId": "OG001", "value": "0.29", "spread": "0.163"}, {"groupId": "OG002", "value": "0.01", "spread": "0.140"}, {"groupId": "OG003", "value": "0.02", "spread": "0.154"}]}]}, {"title": "Change from BL at Week 22 (n=77, 74, 76, 65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.66", "spread": "0.184"}, {"groupId": "OG001", "value": "0.72", "spread": "0.178"}, {"groupId": "OG002", "value": "0.44", "spread": "0.175"}, {"groupId": "OG003", "value": "0.45", "spread": "0.163"}]}]}, {"title": "Change from BL at Week 24 (n=83, 82, 78, 74)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.10", "spread": "0.149"}, {"groupId": "OG001", "value": "0.47", "spread": "0.265"}, {"groupId": "OG002", "value": "0.08", "spread": "0.158"}, {"groupId": "OG003", "value": "-0.06", "spread": "0.142"}]}]}, {"title": "Change from BL at Week 30 (n=77, 78, 79, 67)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.15", "spread": "0.148"}, {"groupId": "OG001", "value": "0.33", "spread": "0.202"}, {"groupId": "OG002", "value": "0.28", "spread": "0.167"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.129"}]}]}, {"title": "Change from BL at Week 37 (n=74, 73, 70, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.21", "spread": "0.163"}, {"groupId": "OG001", "value": "0.42", "spread": "0.204"}, {"groupId": "OG002", "value": "0.12", "spread": "0.189"}, {"groupId": "OG003", "value": "0.14", "spread": "0.159"}]}]}, {"title": "Change from BL at Week 50 (n=67, 69, 71, 61)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.168"}, {"groupId": "OG001", "value": "0.33", "spread": "0.216"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.149"}, {"groupId": "OG003", "value": "0.29", "spread": "0.186"}]}]}, {"title": "Change from BL at Week 63 (n=60, 66, 67, 55)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.12", "spread": "0.176"}, {"groupId": "OG001", "value": "0.20", "spread": "0.221"}, {"groupId": "OG002", "value": "-0.04", "spread": "0.180"}, {"groupId": "OG003", "value": "0.06", "spread": "0.176"}]}]}, {"title": "Change from BL at Week 76 (n=51, 58, 63, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.185"}, {"groupId": "OG001", "value": "0.23", "spread": "0.259"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.158"}, {"groupId": "OG003", "value": "-0.20", "spread": "0.169"}]}]}, {"title": "Change from BL at Week 89 (n=48, 58, 56, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.51", "spread": "0.232"}, {"groupId": "OG001", "value": "0.17", "spread": "0.246"}, {"groupId": "OG002", "value": "-0.10", "spread": "0.152"}, {"groupId": "OG003", "value": "-0.18", "spread": "0.232"}]}]}, {"title": "Change from BL at Week 102 (n=39, 47, 51, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.16", "spread": "0.218"}, {"groupId": "OG001", "value": "0.44", "spread": "0.258"}, {"groupId": "OG002", "value": "0.10", "spread": "0.129"}, {"groupId": "OG003", "value": "-0.09", "spread": "0.208"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 42, 34)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.24", "spread": "0.235"}, {"groupId": "OG001", "value": "0.93", "spread": "0.252"}, {"groupId": "OG002", "value": "0.11", "spread": "0.210"}, {"groupId": "OG003", "value": "0.44", "spread": "0.286"}]}]}, {"title": "Change from BL at Week 128 (n=30, 40, 40, 29)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.58", "spread": "0.227"}, {"groupId": "OG001", "value": "0.66", "spread": "0.314"}, {"groupId": "OG002", "value": "0.44", "spread": "0.221"}, {"groupId": "OG003", "value": "0.22", "spread": "0.286"}]}]}, {"title": "Change from BL at Week 141 (n=28, 39, 34, 28)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.35", "spread": "0.183"}, {"groupId": "OG001", "value": "0.78", "spread": "0.303"}, {"groupId": "OG002", "value": "0.44", "spread": "0.199"}, {"groupId": "OG003", "value": "0.51", "spread": "0.214"}]}]}, {"title": "Change from BL at Week 154 (n=26, 34, 31, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.12", "spread": "0.228"}, {"groupId": "OG001", "value": "0.44", "spread": "0.327"}, {"groupId": "OG002", "value": "0.30", "spread": "0.212"}, {"groupId": "OG003", "value": "0.38", "spread": "0.217"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 25)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.22", "spread": "0.233"}, {"groupId": "OG001", "value": "0.44", "spread": "0.341"}, {"groupId": "OG002", "value": "0.27", "spread": "0.209"}, {"groupId": "OG003", "value": "0.35", "spread": "0.180"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.13", "spread": "0.233"}, {"groupId": "OG001", "value": "0.30", "spread": "0.379"}, {"groupId": "OG002", "value": "0.59", "spread": "0.263"}, {"groupId": "OG003", "value": "0.65", "spread": "0.267"}]}]}, {"title": "Change from BL at Week 193 (n=19, 26, 26, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.34", "spread": "0.220"}, {"groupId": "OG001", "value": "0.02", "spread": "0.403"}, {"groupId": "OG002", "value": "0.60", "spread": "0.205"}, {"groupId": "OG003", "value": "0.19", "spread": "0.157"}]}]}, {"title": "Change from BL at Week 206 (n=17, 22, 23, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.199"}, {"groupId": "OG001", "value": "0.55", "spread": "0.420"}, {"groupId": "OG002", "value": "1.01", "spread": "0.303"}, {"groupId": "OG003", "value": "0.38", "spread": "0.284"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Absolute Neutrophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "x 10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=102, 106, 98, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.00", "spread": "0.141"}, {"groupId": "OG001", "value": "3.98", "spread": "0.142"}, {"groupId": "OG002", "value": "4.16", "spread": "0.137"}, {"groupId": "OG003", "value": "4.01", "spread": "0.148"}]}]}, {"title": "Change from BL at Week 2 (n=95, 99, 92, 86)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.06", "spread": "0.122"}, {"groupId": "OG001", "value": "0.11", "spread": "0.117"}, {"groupId": "OG002", "value": "0.00", "spread": "0.101"}, {"groupId": "OG003", "value": "-0.07", "spread": "0.131"}]}]}, {"title": "Change from BL at Week 4 (n=91, 99, 90, 90)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.09", "spread": "0.114"}, {"groupId": "OG001", "value": "0.16", "spread": "0.103"}, {"groupId": "OG002", "value": "0.05", "spread": "0.121"}, {"groupId": "OG003", "value": "0.23", "spread": "0.120"}]}]}, {"title": "Change from BL at Week 6 (n=89, 95, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.105"}, {"groupId": "OG001", "value": "0.19", "spread": "0.097"}, {"groupId": "OG002", "value": "0.04", "spread": "0.114"}, {"groupId": "OG003", "value": "0.17", "spread": "0.150"}]}]}, {"title": "Change from BL at Week 8 (n=91, 88, 90, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.110"}, {"groupId": "OG001", "value": "0.27", "spread": "0.131"}, {"groupId": "OG002", "value": "0.03", "spread": "0.096"}, {"groupId": "OG003", "value": "0.19", "spread": "0.126"}]}]}, {"title": "Change from BL at Week 10 (n=68, 76, 69, 63)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.18", "spread": "0.135"}, {"groupId": "OG001", "value": "0.48", "spread": "0.145"}, {"groupId": "OG002", "value": "0.17", "spread": "0.139"}, {"groupId": "OG003", "value": "0.45", "spread": "0.169"}]}]}, {"title": "Change from BL at Week 12 (n=83, 88, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.135"}, {"groupId": "OG001", "value": "0.21", "spread": "0.130"}, {"groupId": "OG002", "value": "0.18", "spread": "0.115"}, {"groupId": "OG003", "value": "0.30", "spread": "0.139"}]}]}, {"title": "Change from BL at Week 14 (n=76, 77, 80, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07", "spread": "0.158"}, {"groupId": "OG001", "value": "0.64", "spread": "0.119"}, {"groupId": "OG002", "value": "0.17", "spread": "0.115"}, {"groupId": "OG003", "value": "0.46", "spread": "0.161"}]}]}, {"title": "Change from BL at Week 16 (n=90, 91, 83, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.17", "spread": "0.116"}, {"groupId": "OG001", "value": "0.49", "spread": "0.132"}, {"groupId": "OG002", "value": "0.16", "spread": "0.132"}, {"groupId": "OG003", "value": "0.18", "spread": "0.140"}]}]}, {"title": "Change from BL at Week 18 (n=78, 75, 82, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.23", "spread": "0.120"}, {"groupId": "OG001", "value": "0.67", "spread": "0.149"}, {"groupId": "OG002", "value": "0.32", "spread": "0.130"}, {"groupId": "OG003", "value": "0.21", "spread": "0.148"}]}]}, {"title": "Change from BL at Week 20 (n=83, 79, 78, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.19", "spread": "0.131"}, {"groupId": "OG001", "value": "0.32", "spread": "0.141"}, {"groupId": "OG002", "value": "0.07", "spread": "0.130"}, {"groupId": "OG003", "value": "0.15", "spread": "0.127"}]}]}, {"title": "Change from BL at Week 22 (n=77, 74, 75, 65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.44", "spread": "0.155"}, {"groupId": "OG001", "value": "0.58", "spread": "0.160"}, {"groupId": "OG002", "value": "0.44", "spread": "0.153"}, {"groupId": "OG003", "value": "0.32", "spread": "0.130"}]}]}, {"title": "Change from BL at Week 24 (n=83, 81, 78, 74)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.09", "spread": "0.124"}, {"groupId": "OG001", "value": "0.57", "spread": "0.263"}, {"groupId": "OG002", "value": "0.16", "spread": "0.130"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.115"}]}]}, {"title": "Change from BL at Week 30 (n=76, 78, 79, 67)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.124"}, {"groupId": "OG001", "value": "0.29", "spread": "0.155"}, {"groupId": "OG002", "value": "0.32", "spread": "0.122"}, {"groupId": "OG003", "value": "0.00", "spread": "0.114"}]}]}, {"title": "Change from BL at Week 37 (n=74, 72, 70, 60)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.13", "spread": "0.146"}, {"groupId": "OG001", "value": "0.42", "spread": "0.171"}, {"groupId": "OG002", "value": "0.24", "spread": "0.165"}, {"groupId": "OG003", "value": "0.20", "spread": "0.137"}]}]}, {"title": "Change from BL at Week 50 (n=67, 69, 71, 61)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.144"}, {"groupId": "OG001", "value": "0.40", "spread": "0.182"}, {"groupId": "OG002", "value": "0.19", "spread": "0.128"}, {"groupId": "OG003", "value": "0.27", "spread": "0.161"}]}]}, {"title": "Change from BL at Week 63 (n=60, 66, 67, 55)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.11", "spread": "0.140"}, {"groupId": "OG001", "value": "0.25", "spread": "0.176"}, {"groupId": "OG002", "value": "0.08", "spread": "0.168"}, {"groupId": "OG003", "value": "0.16", "spread": "0.152"}]}]}, {"title": "Change from BL at Week 76 (n=51, 58, 63, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.161"}, {"groupId": "OG001", "value": "0.33", "spread": "0.204"}, {"groupId": "OG002", "value": "0.08", "spread": "0.146"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.140"}]}]}, {"title": "Change from BL at Week 89 (n=48, 58, 56, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.58", "spread": "0.208"}, {"groupId": "OG001", "value": "0.18", "spread": "0.178"}, {"groupId": "OG002", "value": "0.05", "spread": "0.136"}, {"groupId": "OG003", "value": "0.01", "spread": "0.185"}]}]}, {"title": "Change from BL at Week 102 (n=39, 47, 50, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.19", "spread": "0.212"}, {"groupId": "OG001", "value": "0.43", "spread": "0.215"}, {"groupId": "OG002", "value": "0.24", "spread": "0.114"}, {"groupId": "OG003", "value": "0.01", "spread": "0.176"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 42, 34)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.28", "spread": "0.219"}, {"groupId": "OG001", "value": "0.81", "spread": "0.165"}, {"groupId": "OG002", "value": "0.29", "spread": "0.178"}, {"groupId": "OG003", "value": "0.42", "spread": "0.223"}]}]}, {"title": "Change from BL at Week 128 (n=30, 40, 40, 29)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.61", "spread": "0.202"}, {"groupId": "OG001", "value": "0.59", "spread": "0.244"}, {"groupId": "OG002", "value": "0.56", "spread": "0.209"}, {"groupId": "OG003", "value": "0.22", "spread": "0.245"}]}]}, {"title": "Change from BL at Week 141 (n=28, 38, 34, 28)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.41", "spread": "0.168"}, {"groupId": "OG001", "value": "0.80", "spread": "0.254"}, {"groupId": "OG002", "value": "0.45", "spread": "0.161"}, {"groupId": "OG003", "value": "0.40", "spread": "0.198"}]}]}, {"title": "Change from BL at Week 154 (n=26, 33, 31, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.25", "spread": "0.223"}, {"groupId": "OG001", "value": "0.39", "spread": "0.225"}, {"groupId": "OG002", "value": "0.47", "spread": "0.162"}, {"groupId": "OG003", "value": "0.41", "spread": "0.184"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 25)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.211"}, {"groupId": "OG001", "value": "0.56", "spread": "0.239"}, {"groupId": "OG002", "value": "0.27", "spread": "0.193"}, {"groupId": "OG003", "value": "0.33", "spread": "0.176"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.23", "spread": "0.220"}, {"groupId": "OG001", "value": "0.50", "spread": "0.293"}, {"groupId": "OG002", "value": "0.55", "spread": "0.200"}, {"groupId": "OG003", "value": "0.51", "spread": "0.271"}]}]}, {"title": "Change from BL at Week 193 (n=19, 25, 26, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.34", "spread": "0.181"}, {"groupId": "OG001", "value": "0.08", "spread": "0.277"}, {"groupId": "OG002", "value": "0.51", "spread": "0.166"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.130"}]}]}, {"title": "Change from BL at Week 206 (n=17, 22, 23, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.15", "spread": "0.218"}, {"groupId": "OG001", "value": "0.63", "spread": "0.389"}, {"groupId": "OG002", "value": "0.90", "spread": "0.284"}, {"groupId": "OG003", "value": "0.31", "spread": "0.235"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Absolute Lymphocyte Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "x 10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=102, 106, 98, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.16", "spread": "0.062"}, {"groupId": "OG001", "value": "2.21", "spread": "0.071"}, {"groupId": "OG002", "value": "2.14", "spread": "0.063"}, {"groupId": "OG003", "value": "2.22", "spread": "0.063"}]}]}, {"title": "Change from BL at Week 2 (n=95, 99, 92, 86)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.052"}, {"groupId": "OG001", "value": "-0.10", "spread": "0.045"}, {"groupId": "OG002", "value": "-0.11", "spread": "0.046"}, {"groupId": "OG003", "value": "-0.13", "spread": "0.049"}]}]}, {"title": "Change from BL at Week 4 (n=91, 99, 90, 90)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.056"}, {"groupId": "OG001", "value": "-0.12", "spread": "0.046"}, {"groupId": "OG002", "value": "-0.18", "spread": "0.046"}, {"groupId": "OG003", "value": "-0.04", "spread": "0.040"}]}]}, {"title": "Change from BL at Week 6 (n=89, 95, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.049"}, {"groupId": "OG001", "value": "-0.09", "spread": "0.057"}, {"groupId": "OG002", "value": "-0.23", "spread": "0.047"}, {"groupId": "OG003", "value": "-0.09", "spread": "0.048"}]}]}, {"title": "Change from BL at Week 8 (n=91, 88, 90, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.07", "spread": "0.049"}, {"groupId": "OG001", "value": "-0.11", "spread": "0.049"}, {"groupId": "OG002", "value": "-0.20", "spread": "0.048"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.053"}]}]}, {"title": "Change from BL at Week 10 (n=68, 76, 69, 63)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07", "spread": "0.069"}, {"groupId": "OG001", "value": "0.02", "spread": "0.055"}, {"groupId": "OG002", "value": "-0.10", "spread": "0.053"}, {"groupId": "OG003", "value": "0.05", "spread": "0.068"}]}]}, {"title": "Change from BL at Week 12 (n=83, 88, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.06", "spread": "0.049"}, {"groupId": "OG001", "value": "-0.12", "spread": "0.044"}, {"groupId": "OG002", "value": "-0.16", "spread": "0.052"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.058"}]}]}, {"title": "Change from BL at Week 14 (n=76, 77, 80, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.20", "spread": "0.071"}, {"groupId": "OG001", "value": "0.08", "spread": "0.085"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.052"}, {"groupId": "OG003", "value": "0.06", "spread": "0.058"}]}]}, {"title": "Change from BL at Week 16 (n=90, 91, 83, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.065"}, {"groupId": "OG001", "value": "0.01", "spread": "0.057"}, {"groupId": "OG002", "value": "-0.11", "spread": "0.049"}, {"groupId": "OG003", "value": "0.01", "spread": "0.061"}]}]}, {"title": "Change from BL at Week 18 (n=78, 75, 82, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.11", "spread": "0.079"}, {"groupId": "OG001", "value": "0.13", "spread": "0.064"}, {"groupId": "OG002", "value": "0.01", "spread": "0.064"}, {"groupId": "OG003", "value": "0.08", "spread": "0.069"}]}]}, {"title": "Change from BL at Week 20 (n=83, 79, 78, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08", "spread": "0.065"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.064"}, {"groupId": "OG002", "value": "-0.10", "spread": "0.058"}, {"groupId": "OG003", "value": "-0.11", "spread": "0.052"}]}]}, {"title": "Change from BL at Week 22 (n=77, 74, 75, 65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.16", "spread": "0.069"}, {"groupId": "OG001", "value": "0.13", "spread": "0.083"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.060"}, {"groupId": "OG003", "value": "0.09", "spread": "0.067"}]}]}, {"title": "Change from BL at Week 24 (n=83, 81, 78, 74)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.068"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.071"}, {"groupId": "OG002", "value": "-0.13", "spread": "0.054"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.059"}]}]}, {"title": "Change from BL at Week 30 (n=76, 78, 79, 67)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08", "spread": "0.066"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.060"}, {"groupId": "OG002", "value": "-0.09", "spread": "0.063"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.059"}]}]}, {"title": "Change from BL at Week 37 (n=74, 72, 70, 60)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.067"}, {"groupId": "OG001", "value": "0.02", "spread": "0.064"}, {"groupId": "OG002", "value": "-0.17", "spread": "0.056"}, {"groupId": "OG003", "value": "-0.08", "spread": "0.066"}]}]}, {"title": "Change from BL at Week 50 (n=67, 69, 71, 61)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.06", "spread": "0.071"}, {"groupId": "OG001", "value": "-0.09", "spread": "0.069"}, {"groupId": "OG002", "value": "-0.25", "spread": "0.051"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.059"}]}]}, {"title": "Change from BL at Week 63 (n=60, 66, 67, 55)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.06", "spread": "0.077"}, {"groupId": "OG001", "value": "-0.10", "spread": "0.063"}, {"groupId": "OG002", "value": "-0.19", "spread": "0.070"}, {"groupId": "OG003", "value": "-0.16", "spread": "0.063"}]}]}, {"title": "Change from BL at Week 76 (n=51, 58, 63, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.10", "spread": "0.086"}, {"groupId": "OG001", "value": "-0.09", "spread": "0.082"}, {"groupId": "OG002", "value": "-0.18", "spread": "0.054"}, {"groupId": "OG003", "value": "-0.20", "spread": "0.072"}]}]}, {"title": "Change from BL at Week 89 (n=49, 58, 56, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.12", "spread": "0.087"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.080"}, {"groupId": "OG002", "value": "-0.19", "spread": "0.054"}, {"groupId": "OG003", "value": "-0.23", "spread": "0.083"}]}]}, {"title": "Change from BL at Week 102 (n=39, 48, 51, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.17", "spread": "0.081"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.086"}, {"groupId": "OG002", "value": "-0.23", "spread": "0.056"}, {"groupId": "OG003", "value": "-0.16", "spread": "0.071"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 43, 35)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.15", "spread": "0.080"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.103"}, {"groupId": "OG002", "value": "-0.21", "spread": "0.068"}, {"groupId": "OG003", "value": "-0.10", "spread": "0.100"}]}]}, {"title": "Change from BL at Week 128 (n=30, 40, 40, 30)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.12", "spread": "0.106"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.105"}, {"groupId": "OG002", "value": "-0.16", "spread": "0.068"}, {"groupId": "OG003", "value": "-0.06", "spread": "0.094"}]}]}, {"title": "Change from BL at Week 141 (n=28, 38, 34, 28)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.13", "spread": "0.089"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.083"}, {"groupId": "OG002", "value": "-0.10", "spread": "0.079"}, {"groupId": "OG003", "value": "0.00", "spread": "0.086"}]}]}, {"title": "Change from BL at Week 154 (n=26, 33, 31, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.23", "spread": "0.096"}, {"groupId": "OG001", "value": "0.04", "spread": "0.128"}, {"groupId": "OG002", "value": "-0.23", "spread": "0.101"}, {"groupId": "OG003", "value": "-0.14", "spread": "0.096"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 25)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.23", "spread": "0.096"}, {"groupId": "OG001", "value": "-0.13", "spread": "0.118"}, {"groupId": "OG002", "value": "-0.11", "spread": "0.090"}, {"groupId": "OG003", "value": "-0.16", "spread": "0.084"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.15", "spread": "0.107"}, {"groupId": "OG001", "value": "-0.22", "spread": "0.130"}, {"groupId": "OG002", "value": "-0.06", "spread": "0.105"}, {"groupId": "OG003", "value": "-0.05", "spread": "0.102"}]}]}, {"title": "Change from BL at Week 193 (n=19, 25, 26, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.06", "spread": "0.094"}, {"groupId": "OG001", "value": "-0.09", "spread": "0.151"}, {"groupId": "OG002", "value": "-0.04", "spread": "0.092"}, {"groupId": "OG003", "value": "0.01", "spread": "0.101"}]}]}, {"title": "Change from BL at Week 206 (n=17, 22, 23, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.17", "spread": "0.126"}, {"groupId": "OG001", "value": "-0.14", "spread": "0.105"}, {"groupId": "OG002", "value": "-0.05", "spread": "0.094"}, {"groupId": "OG003", "value": "-0.08", "spread": "0.113"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Absolute Monocyte Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "x 10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=102, 106, 98, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.31", "spread": "0.016"}, {"groupId": "OG001", "value": "0.34", "spread": "0.017"}, {"groupId": "OG002", "value": "0.32", "spread": "0.016"}, {"groupId": "OG003", "value": "0.32", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 2 (n=95, 99, 92, 86)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.015"}, {"groupId": "OG001", "value": "0.01", "spread": "0.017"}, {"groupId": "OG002", "value": "-0.05", "spread": "0.021"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 4 (n=91, 99, 90, 90)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.015"}, {"groupId": "OG001", "value": "0.00", "spread": "0.014"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.020"}, {"groupId": "OG003", "value": "0.01", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 6 (n=89, 95, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.017"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.017"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.019"}, {"groupId": "OG003", "value": "0.02", "spread": "0.019"}]}]}, {"title": "Change from BL at Week 8 (n=91, 88, 90, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.016"}, {"groupId": "OG001", "value": "0.03", "spread": "0.018"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.017"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 10 (n=68, 76, 69, 63)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08", "spread": "0.020"}, {"groupId": "OG001", "value": "0.04", "spread": "0.021"}, {"groupId": "OG002", "value": "0.04", "spread": "0.021"}, {"groupId": "OG003", "value": "0.03", "spread": "0.024"}]}]}, {"title": "Change from BL at Week 12 (n=83, 88, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.017"}, {"groupId": "OG001", "value": "0.00", "spread": "0.018"}, {"groupId": "OG002", "value": "0.00", "spread": "0.019"}, {"groupId": "OG003", "value": "0.01", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 14 (n=76, 77, 80, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.09", "spread": "0.019"}, {"groupId": "OG001", "value": "0.06", "spread": "0.022"}, {"groupId": "OG002", "value": "0.03", "spread": "0.021"}, {"groupId": "OG003", "value": "0.04", "spread": "0.021"}]}]}, {"title": "Change from BL at Week 16 (n=90, 91, 83, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.018"}, {"groupId": "OG001", "value": "0.04", "spread": "0.019"}, {"groupId": "OG002", "value": "0.04", "spread": "0.019"}, {"groupId": "OG003", "value": "0.01", "spread": "0.017"}]}]}, {"title": "Change from BL at Week 18 (n=78, 75, 82, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.018"}, {"groupId": "OG001", "value": "0.05", "spread": "0.025"}, {"groupId": "OG002", "value": "0.06", "spread": "0.018"}, {"groupId": "OG003", "value": "0.04", "spread": "0.021"}]}]}, {"title": "Change from BL at Week 20 (n=83, 79, 78, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.017"}, {"groupId": "OG001", "value": "0.02", "spread": "0.018"}, {"groupId": "OG002", "value": "0.04", "spread": "0.021"}, {"groupId": "OG003", "value": "0.01", "spread": "0.022"}]}]}, {"title": "Change from BL at Week 22 (n=77, 74, 75, 65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08", "spread": "0.023"}, {"groupId": "OG001", "value": "0.05", "spread": "0.017"}, {"groupId": "OG002", "value": "0.06", "spread": "0.021"}, {"groupId": "OG003", "value": "0.05", "spread": "0.021"}]}]}, {"title": "Change from BL at Week 24 (n=83, 81, 78, 74)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.019"}, {"groupId": "OG001", "value": "0.01", "spread": "0.019"}, {"groupId": "OG002", "value": "0.03", "spread": "0.019"}, {"groupId": "OG003", "value": "0.03", "spread": "0.019"}]}]}, {"title": "Change from BL at Week 30 (n=76, 78, 79, 67)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.020"}, {"groupId": "OG001", "value": "0.03", "spread": "0.022"}, {"groupId": "OG002", "value": "0.04", "spread": "0.021"}, {"groupId": "OG003", "value": "0.03", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 37 (n=74, 72, 70, 60)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.022"}, {"groupId": "OG001", "value": "0.02", "spread": "0.022"}, {"groupId": "OG002", "value": "0.04", "spread": "0.020"}, {"groupId": "OG003", "value": "0.00", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 50 (n=67, 69, 71, 61)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07", "spread": "0.021"}, {"groupId": "OG001", "value": "0.03", "spread": "0.020"}, {"groupId": "OG002", "value": "0.05", "spread": "0.022"}, {"groupId": "OG003", "value": "0.06", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 63 (n=60, 66, 67, 55)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08", "spread": "0.021"}, {"groupId": "OG001", "value": "0.05", "spread": "0.022"}, {"groupId": "OG002", "value": "0.07", "spread": "0.026"}, {"groupId": "OG003", "value": "0.07", "spread": "0.019"}]}]}, {"title": "Change from BL at Week 76 (n=51, 58, 63, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.12", "spread": "0.026"}, {"groupId": "OG001", "value": "0.04", "spread": "0.028"}, {"groupId": "OG002", "value": "0.06", "spread": "0.024"}, {"groupId": "OG003", "value": "0.05", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 89 (n=48, 58, 56, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.11", "spread": "0.023"}, {"groupId": "OG001", "value": "0.03", "spread": "0.026"}, {"groupId": "OG002", "value": "0.08", "spread": "0.022"}, {"groupId": "OG003", "value": "0.05", "spread": "0.028"}]}]}, {"title": "Change from BL at Week 102 (n=39, 47, 50, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.14", "spread": "0.025"}, {"groupId": "OG001", "value": "0.04", "spread": "0.028"}, {"groupId": "OG002", "value": "0.09", "spread": "0.028"}, {"groupId": "OG003", "value": "0.07", "spread": "0.025"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 42, 34)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.12", "spread": "0.033"}, {"groupId": "OG001", "value": "0.05", "spread": "0.026"}, {"groupId": "OG002", "value": "0.06", "spread": "0.029"}, {"groupId": "OG003", "value": "0.13", "spread": "0.030"}]}]}, {"title": "Change from BL at Week 128 (n=30, 40, 40, 29)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.12", "spread": "0.031"}, {"groupId": "OG001", "value": "0.04", "spread": "0.031"}, {"groupId": "OG002", "value": "0.07", "spread": "0.026"}, {"groupId": "OG003", "value": "0.07", "spread": "0.022"}]}]}, {"title": "Change from BL at Week 141 (n=28, 38, 34, 28)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08", "spread": "0.029"}, {"groupId": "OG001", "value": "0.02", "spread": "0.030"}, {"groupId": "OG002", "value": "0.10", "spread": "0.028"}, {"groupId": "OG003", "value": "0.10", "spread": "0.024"}]}]}, {"title": "Change from BL at Week 154 (n=26, 33, 31, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.10", "spread": "0.025"}, {"groupId": "OG001", "value": "0.05", "spread": "0.037"}, {"groupId": "OG002", "value": "0.06", "spread": "0.035"}, {"groupId": "OG003", "value": "0.08", "spread": "0.022"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 25)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07", "spread": "0.029"}, {"groupId": "OG001", "value": "0.04", "spread": "0.036"}, {"groupId": "OG002", "value": "0.10", "spread": "0.036"}, {"groupId": "OG003", "value": "0.11", "spread": "0.023"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08", "spread": "0.028"}, {"groupId": "OG001", "value": "0.04", "spread": "0.041"}, {"groupId": "OG002", "value": "0.11", "spread": "0.040"}, {"groupId": "OG003", "value": "0.11", "spread": "0.021"}]}]}, {"title": "Change from BL at Week 193 (n=19, 25, 26, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.09", "spread": "0.039"}, {"groupId": "OG001", "value": "0.04", "spread": "0.044"}, {"groupId": "OG002", "value": "0.11", "spread": "0.036"}, {"groupId": "OG003", "value": "0.13", "spread": "0.023"}]}]}, {"title": "Change from BL at Week 206 (n=17, 22, 23, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.033"}, {"groupId": "OG001", "value": "0.05", "spread": "0.034"}, {"groupId": "OG002", "value": "0.13", "spread": "0.042"}, {"groupId": "OG003", "value": "0.09", "spread": "0.023"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Absolute Basophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "x 10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=102, 106, 98, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.003"}, {"groupId": "OG001", "value": "0.02", "spread": "0.004"}, {"groupId": "OG002", "value": "0.02", "spread": "0.004"}, {"groupId": "OG003", "value": "0.02", "spread": "0.004"}]}]}, {"title": "Change from BL at Week 2 (n=95, 99, 92, 86)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG003", "value": "0.00", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 4 (n=91, 99, 90, 90)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 6 (n=89, 95, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.005"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 8 (n=91, 88, 90, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.005"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 10 (n=68, 76, 69, 63)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 12 (n=83, 88, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.005"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.004"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 14 (n=76, 77, 80, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "0.00", "spread": "0.006"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 16 (n=90, 91, 83, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.005"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.006"}]}]}, {"title": "Change from BL at Week 18 (n=78, 75, 82, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "0.00", "spread": "0.005"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.006"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 20 (n=83, 79, 78, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.004"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.005"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 22 (n=77, 74, 75, 65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.004"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.005"}, {"groupId": "OG002", "value": "0.00", "spread": "0.013"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.006"}]}]}, {"title": "Change from BL at Week 24 (n=83, 81, 78, 74)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.005"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.004"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.005"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.006"}]}]}, {"title": "Change from BL at Week 30 (n=76, 78, 79, 67)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "0.01", "spread": "0.006"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.005"}, {"groupId": "OG003", "value": "0.01", "spread": "0.006"}]}]}, {"title": "Change from BL at Week 37 (n=74, 72, 70, 60)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "0.01", "spread": "0.006"}, {"groupId": "OG002", "value": "0.00", "spread": "0.005"}, {"groupId": "OG003", "value": "0.00", "spread": "0.007"}]}]}, {"title": "Change from BL at Week 50 (n=67, 69, 71, 61)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.004"}, {"groupId": "OG001", "value": "0.01", "spread": "0.006"}, {"groupId": "OG002", "value": "0.01", "spread": "0.005"}, {"groupId": "OG003", "value": "0.02", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 63 (n=60, 66, 67, 55)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.005"}, {"groupId": "OG001", "value": "0.01", "spread": "0.005"}, {"groupId": "OG002", "value": "0.02", "spread": "0.006"}, {"groupId": "OG003", "value": "0.02", "spread": "0.004"}]}]}, {"title": "Change from BL at Week 76 (n=51, 58, 63, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.004"}, {"groupId": "OG001", "value": "0.01", "spread": "0.005"}, {"groupId": "OG002", "value": "0.02", "spread": "0.005"}, {"groupId": "OG003", "value": "0.01", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 89 (n=48, 58, 56, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.006"}, {"groupId": "OG001", "value": "0.02", "spread": "0.006"}, {"groupId": "OG002", "value": "0.02", "spread": "0.005"}, {"groupId": "OG003", "value": "0.02", "spread": "0.006"}]}]}, {"title": "Change from BL at Week 102 (n=39, 47, 50, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.007"}, {"groupId": "OG001", "value": "0.02", "spread": "0.005"}, {"groupId": "OG002", "value": "0.02", "spread": "0.005"}, {"groupId": "OG003", "value": "0.02", "spread": "0.007"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 42, 34)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.006"}, {"groupId": "OG001", "value": "0.03", "spread": "0.007"}, {"groupId": "OG002", "value": "0.01", "spread": "0.007"}, {"groupId": "OG003", "value": "0.03", "spread": "0.008"}]}]}, {"title": "Change from BL at Week 128 (n=30, 40, 40, 29)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.008"}, {"groupId": "OG001", "value": "0.03", "spread": "0.007"}, {"groupId": "OG002", "value": "0.01", "spread": "0.006"}, {"groupId": "OG003", "value": "0.03", "spread": "0.008"}]}]}, {"title": "Change from BL at Week 141 (n=28, 38, 34, 28)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.008"}, {"groupId": "OG001", "value": "0.02", "spread": "0.007"}, {"groupId": "OG002", "value": "0.01", "spread": "0.007"}, {"groupId": "OG003", "value": "0.02", "spread": "0.009"}]}]}, {"title": "Change from BL at Week 154 (n=26, 33, 31, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.008"}, {"groupId": "OG001", "value": "0.02", "spread": "0.006"}, {"groupId": "OG002", "value": "0.02", "spread": "0.009"}, {"groupId": "OG003", "value": "0.01", "spread": "0.010"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 25)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.009"}, {"groupId": "OG001", "value": "0.01", "spread": "0.008"}, {"groupId": "OG002", "value": "0.01", "spread": "0.008"}, {"groupId": "OG003", "value": "0.02", "spread": "0.008"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.007"}, {"groupId": "OG001", "value": "0.02", "spread": "0.007"}, {"groupId": "OG002", "value": "0.00", "spread": "0.007"}, {"groupId": "OG003", "value": "0.02", "spread": "0.009"}]}]}, {"title": "Change from BL at Week 193 (n=19, 25, 26, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.010"}, {"groupId": "OG001", "value": "0.01", "spread": "0.009"}, {"groupId": "OG002", "value": "0.01", "spread": "0.008"}, {"groupId": "OG003", "value": "0.02", "spread": "0.008"}]}]}, {"title": "Change from BL at Week 206 (n=17, 22, 23, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.013"}, {"groupId": "OG001", "value": "0.02", "spread": "0.010"}, {"groupId": "OG002", "value": "0.01", "spread": "0.010"}, {"groupId": "OG003", "value": "0.01", "spread": "0.009"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Absolute Eosinophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "x 10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=102, 106, 98, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.18", "spread": "0.012"}, {"groupId": "OG001", "value": "0.20", "spread": "0.015"}, {"groupId": "OG002", "value": "0.20", "spread": "0.012"}, {"groupId": "OG003", "value": "0.20", "spread": "0.016"}]}]}, {"title": "Change from BL at Week 2 (n=95, 99, 92, 86)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.008"}, {"groupId": "OG001", "value": "0.01", "spread": "0.011"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.009"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 4 (n=91, 99, 90, 90)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.011"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.012"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.011"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.012"}]}]}, {"title": "Change from BL at Week 6 (n=89, 95, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.009"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.012"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.011"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.014"}]}]}, {"title": "Change from BL at Week 8 (n=91, 88, 90, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.011"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.014"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.012"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 10 (n=68, 76, 69, 63)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.014"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.015"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.013"}, {"groupId": "OG003", "value": "0.01", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 12 (n=83, 88, 87, 82)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.024"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.014"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.015"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 14 (n=76, 77, 80, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.015"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.017"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.019"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.017"}]}]}, {"title": "Change from BL at Week 16 (n=90, 91, 83, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.010"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.014"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.014"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 18 (n=78, 75, 82, 71)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.011"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.018"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.013"}, {"groupId": "OG003", "value": "0.00", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 20 (n=83, 79, 78, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.012"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.015"}, {"groupId": "OG002", "value": "-0.04", "spread": "0.012"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.016"}]}]}, {"title": "Change from BL at Week 22 (n=77, 74, 75, 65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.015"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.013"}, {"groupId": "OG002", "value": "-0.04", "spread": "0.012"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.016"}]}]}, {"title": "Change from BL at Week 24 (n=83, 81, 78, 74)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.013"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.015"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.011"}, {"groupId": "OG003", "value": "-0.04", "spread": "0.016"}]}]}, {"title": "Change from BL at Week 30 (n=76, 78, 79, 67)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.013"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.017"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.011"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.016"}]}]}, {"title": "Change from BL at Week 37 (n=74, 72, 70, 60)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.010"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.019"}, {"groupId": "OG002", "value": "-0.04", "spread": "0.012"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 50 (n=67, 69, 71, 61)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.013"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.019"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.011"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 63 (n=60, 66, 67, 55)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.019"}, {"groupId": "OG001", "value": "0.00", "spread": "0.025"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.017"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 76 (n=51, 58, 63, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.014"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.022"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.013"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 89 (n=48, 58, 56, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.019"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.025"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.013"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 102 (n=39, 47, 50, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.025"}, {"groupId": "OG001", "value": "0.01", "spread": "0.027"}, {"groupId": "OG002", "value": "0.02", "spread": "0.016"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 42, 34)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.019"}, {"groupId": "OG001", "value": "0.07", "spread": "0.051"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.019"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.023"}]}]}, {"title": "Change from BL at Week 128 (n=30, 40, 40, 29)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.017"}, {"groupId": "OG001", "value": "0.02", "spread": "0.046"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.014"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.025"}]}]}, {"title": "Change from BL at Week 141 (n=28, 38, 34, 28)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.020"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.019"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.016"}, {"groupId": "OG003", "value": "0.01", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 154 (n=26, 33, 31, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.017"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.019"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.018"}, {"groupId": "OG003", "value": "0.03", "spread": "0.021"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 25)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.014"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.020"}, {"groupId": "OG002", "value": "0.01", "spread": "0.017"}, {"groupId": "OG003", "value": "0.06", "spread": "0.039"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.013"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.021"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.014"}, {"groupId": "OG003", "value": "0.07", "spread": "0.040"}]}]}, {"title": "Change from BL at Week 193 (n=19, 25, 26, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.019"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.024"}, {"groupId": "OG002", "value": "0.00", "spread": "0.017"}, {"groupId": "OG003", "value": "0.05", "spread": "0.032"}]}]}, {"title": "Change from BL at Week 206 (n=17, 22, 23, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.026"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.028"}, {"groupId": "OG002", "value": "0.03", "spread": "0.016"}, {"groupId": "OG003", "value": "0.06", "spread": "0.026"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Changes From Baseline in Systolic Blood Pressure During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mmHg", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Change from BL at Week 2 (n=96, 100, 94, 89)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.0", "spread": "1.4"}, {"groupId": "OG001", "value": "-2.0", "spread": "1.3"}, {"groupId": "OG002", "value": "-2.3", "spread": "1.2"}, {"groupId": "OG003", "value": "-3.1", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 4 (n=96, 100, 92, 91)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.9", "spread": "1.4"}, {"groupId": "OG001", "value": "-1.2", "spread": "1.1"}, {"groupId": "OG002", "value": "-2.3", "spread": "1.1"}, {"groupId": "OG003", "value": "-4.3", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 6 (n=91, 98, 88, 84)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.5", "spread": "1.4"}, {"groupId": "OG001", "value": "-2.1", "spread": "1.2"}, {"groupId": "OG002", "value": "-3.5", "spread": "1.3"}, {"groupId": "OG003", "value": "-4.5", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 8 (n=94, 91, 91, 80)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.0", "spread": "1.4"}, {"groupId": "OG001", "value": "-1.8", "spread": "1.2"}, {"groupId": "OG002", "value": "-4.0", "spread": "1.2"}, {"groupId": "OG003", "value": "-5.5", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 10 (n=51, 66, 51, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.6", "spread": "2.0"}, {"groupId": "OG001", "value": "-2.9", "spread": "1.5"}, {"groupId": "OG002", "value": "-5.0", "spread": "1.5"}, {"groupId": "OG003", "value": "-6.1", "spread": "1.7"}]}]}, {"title": "Change from BL at Week 12 (n=82, 83, 87, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.3", "spread": "1.3"}, {"groupId": "OG001", "value": "-2.9", "spread": "1.2"}, {"groupId": "OG002", "value": "-2.8", "spread": "1.3"}, {"groupId": "OG003", "value": "-3.2", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 14 (n=65, 72, 66, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.9", "spread": "1.6"}, {"groupId": "OG001", "value": "-2.0", "spread": "1.5"}, {"groupId": "OG002", "value": "-6.0", "spread": "1.7"}, {"groupId": "OG003", "value": "-1.9", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 16 (n=87, 87, 81, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.2", "spread": "1.4"}, {"groupId": "OG001", "value": "-2.1", "spread": "1.3"}, {"groupId": "OG002", "value": "-3.8", "spread": "1.4"}, {"groupId": "OG003", "value": "-2.1", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 18 (n=73, 69, 76, 66)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.1", "spread": "1.7"}, {"groupId": "OG001", "value": "-0.9", "spread": "1.5"}, {"groupId": "OG002", "value": "-4.3", "spread": "1.7"}, {"groupId": "OG003", "value": "-4.7", "spread": "1.9"}]}]}, {"title": "Change from BL at Week 20 (n=84, 80, 76, 73)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.0", "spread": "1.6"}, {"groupId": "OG001", "value": "-3.2", "spread": "1.3"}, {"groupId": "OG002", "value": "-3.3", "spread": "1.4"}, {"groupId": "OG003", "value": "-4.9", "spread": "1.7"}]}]}, {"title": "Change from BL at Week 22 (n=78, 73, 76, 64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-6.1", "spread": "1.7"}, {"groupId": "OG001", "value": "-4.5", "spread": "1.3"}, {"groupId": "OG002", "value": "-5.9", "spread": "1.5"}, {"groupId": "OG003", "value": "-3.9", "spread": "1.9"}]}]}, {"title": "Change from BL at Week 24 (n=84, 83, 77, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.8", "spread": "1.5"}, {"groupId": "OG001", "value": "-4.1", "spread": "1.2"}, {"groupId": "OG002", "value": "-6.2", "spread": "1.5"}, {"groupId": "OG003", "value": "-6.3", "spread": "1.7"}]}]}, {"title": "Change from BL at Week 30 (n=79, 78, 79, 66)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.6", "spread": "1.7"}, {"groupId": "OG001", "value": "-3.8", "spread": "1.5"}, {"groupId": "OG002", "value": "-3.9", "spread": "1.5"}, {"groupId": "OG003", "value": "-5.4", "spread": "1.9"}]}]}, {"title": "Change from BL at Week 37 (n=77, 74, 71, 66)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.0", "spread": "1.7"}, {"groupId": "OG001", "value": "-3.5", "spread": "1.4"}, {"groupId": "OG002", "value": "-5.2", "spread": "1.5"}, {"groupId": "OG003", "value": "-3.6", "spread": "1.7"}]}]}, {"title": "Change from BL at Week 50 (n=70, 73, 73, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.5", "spread": "1.7"}, {"groupId": "OG001", "value": "0.1", "spread": "1.4"}, {"groupId": "OG002", "value": "-3.3", "spread": "1.5"}, {"groupId": "OG003", "value": "-0.4", "spread": "1.9"}]}]}, {"title": "Change from BL at Week 63 (n=62, 66, 69, 56)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.2", "spread": "1.9"}, {"groupId": "OG001", "value": "-0.3", "spread": "1.4"}, {"groupId": "OG002", "value": "-1.1", "spread": "1.5"}, {"groupId": "OG003", "value": "-2.4", "spread": "2.1"}]}]}, {"title": "Change from BL at Week 76 (n=53, 59, 64, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.9", "spread": "1.7"}, {"groupId": "OG001", "value": "-2.6", "spread": "1.6"}, {"groupId": "OG002", "value": "-3.1", "spread": "1.8"}, {"groupId": "OG003", "value": "-0.9", "spread": "2.2"}]}]}, {"title": "Change from BL at Week 89 (n=49, 58, 56, 44)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.8", "spread": "2.0"}, {"groupId": "OG001", "value": "-3.4", "spread": "1.4"}, {"groupId": "OG002", "value": "-5.4", "spread": "2.0"}, {"groupId": "OG003", "value": "-2.2", "spread": "2.2"}]}]}, {"title": "Change from BL at Week 102 (n=42, 47, 50, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "2.1"}, {"groupId": "OG001", "value": "-1.1", "spread": "1.9"}, {"groupId": "OG002", "value": "-2.9", "spread": "2.1"}, {"groupId": "OG003", "value": "-1.0", "spread": "2.5"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 43, 37)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.6", "spread": "2.4"}, {"groupId": "OG001", "value": "-2.6", "spread": "2.0"}, {"groupId": "OG002", "value": "-1.6", "spread": "1.9"}, {"groupId": "OG003", "value": "0.9", "spread": "2.7"}]}]}, {"title": "Change from BL at Week 128 (n=31, 40, 41, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.1", "spread": "2.5"}, {"groupId": "OG001", "value": "-5.5", "spread": "1.9"}, {"groupId": "OG002", "value": "0.0", "spread": "1.9"}, {"groupId": "OG003", "value": "1.1", "spread": "2.7"}]}]}, {"title": "Change from BL at Week 141 (n=29, 40, 35, 29)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.8", "spread": "3.0"}, {"groupId": "OG001", "value": "-5.2", "spread": "2.3"}, {"groupId": "OG002", "value": "0.3", "spread": "2.6"}, {"groupId": "OG003", "value": "-1.4", "spread": "3.1"}]}]}, {"title": "Change from BL at Week 154 (n=27, 36, 33, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "2.8"}, {"groupId": "OG001", "value": "-0.5", "spread": "2.3"}, {"groupId": "OG002", "value": "3.5", "spread": "2.6"}, {"groupId": "OG003", "value": "2.3", "spread": "3.1"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7", "spread": "2.9"}, {"groupId": "OG001", "value": "-1.8", "spread": "2.5"}, {"groupId": "OG002", "value": "4.0", "spread": "2.5"}, {"groupId": "OG003", "value": "-0.6", "spread": "3.1"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.9", "spread": "2.9"}, {"groupId": "OG001", "value": "-5.4", "spread": "3.2"}, {"groupId": "OG002", "value": "0.9", "spread": "2.4"}, {"groupId": "OG003", "value": "-0.8", "spread": "2.6"}]}]}, {"title": "Change from BL at Week 193 (n=19, 26, 27, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.4", "spread": "4.0"}, {"groupId": "OG001", "value": "-7.5", "spread": "3.2"}, {"groupId": "OG002", "value": "0.0", "spread": "3.0"}, {"groupId": "OG003", "value": "-2.6", "spread": "3.6"}]}]}, {"title": "Change from BL at Week 206 (n=17, 24, 24, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.8", "spread": "5.0"}, {"groupId": "OG001", "value": "-2.8", "spread": "3.3"}, {"groupId": "OG002", "value": "2.3", "spread": "2.6"}, {"groupId": "OG003", "value": "0.7", "spread": "4.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mmHg", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Change from BL at Week 2 (n=96, 100, 94, 89)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.0", "spread": "0.7"}, {"groupId": "OG001", "value": "-1.2", "spread": "0.8"}, {"groupId": "OG002", "value": "-0.5", "spread": "0.7"}, {"groupId": "OG003", "value": "-1.5", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 4 (n=96, 100, 92, 91)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.4", "spread": "0.7"}, {"groupId": "OG001", "value": "-1.1", "spread": "0.8"}, {"groupId": "OG002", "value": "0.3", "spread": "0.8"}, {"groupId": "OG003", "value": "-1.8", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 6 (n=91, 98, 88, 84)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.5", "spread": "0.8"}, {"groupId": "OG001", "value": "-0.9", "spread": "0.8"}, {"groupId": "OG002", "value": "-0.8", "spread": "0.9"}, {"groupId": "OG003", "value": "-1.9", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 8 (n=94, 91, 91, 80)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.4", "spread": "0.9"}, {"groupId": "OG001", "value": "-0.9", "spread": "0.8"}, {"groupId": "OG002", "value": "-0.7", "spread": "0.8"}, {"groupId": "OG003", "value": "-2.4", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 10 (n=51, 66, 51, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "1.2"}, {"groupId": "OG001", "value": "-1.1", "spread": "1.1"}, {"groupId": "OG002", "value": "-1.3", "spread": "0.9"}, {"groupId": "OG003", "value": "-3.4", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 12 (n=82, 83, 87, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.3", "spread": "0.9"}, {"groupId": "OG001", "value": "-2.0", "spread": "0.9"}, {"groupId": "OG002", "value": "-0.7", "spread": "0.8"}, {"groupId": "OG003", "value": "-1.8", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 14 (n=65, 72, 66, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.5", "spread": "0.9"}, {"groupId": "OG001", "value": "-2.4", "spread": "1.1"}, {"groupId": "OG002", "value": "-2.4", "spread": "1.0"}, {"groupId": "OG003", "value": "-2.7", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 16 (n=87, 87, 81, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.5", "spread": "0.9"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.8"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.9"}, {"groupId": "OG003", "value": "-2.1", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 18 (n=73, 69, 76, 66)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.3", "spread": "1.0"}, {"groupId": "OG001", "value": "-1.6", "spread": "0.9"}, {"groupId": "OG002", "value": "-1.9", "spread": "0.9"}, {"groupId": "OG003", "value": "-2.1", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 20 (n=84, 80, 76, 73)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.2", "spread": "0.9"}, {"groupId": "OG001", "value": "-1.8", "spread": "0.9"}, {"groupId": "OG002", "value": "-1.9", "spread": "1.0"}, {"groupId": "OG003", "value": "-2.2", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 22 (n=78, 73, 76, 64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.0", "spread": "0.9"}, {"groupId": "OG001", "value": "-2.0", "spread": "0.9"}, {"groupId": "OG002", "value": "-2.5", "spread": "0.9"}, {"groupId": "OG003", "value": "-1.7", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 24 (n=84, 83, 77, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.5", "spread": "1.0"}, {"groupId": "OG001", "value": "-1.7", "spread": "0.8"}, {"groupId": "OG002", "value": "-2.3", "spread": "0.9"}, {"groupId": "OG003", "value": "-3.4", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 30 (n=79, 78, 79, 66)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.4", "spread": "0.9"}, {"groupId": "OG001", "value": "-2.2", "spread": "0.9"}, {"groupId": "OG002", "value": "-0.3", "spread": "0.9"}, {"groupId": "OG003", "value": "-2.8", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 37 (n=77, 74, 71, 66)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "1.1"}, {"groupId": "OG001", "value": "-1.7", "spread": "0.9"}, {"groupId": "OG002", "value": "-0.6", "spread": "1.0"}, {"groupId": "OG003", "value": "-2.0", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 50 (n=70, 73, 73, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.7", "spread": "1.2"}, {"groupId": "OG001", "value": "0.3", "spread": "0.8"}, {"groupId": "OG002", "value": "-0.3", "spread": "1.0"}, {"groupId": "OG003", "value": "-0.6", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 63 (n=61, 66, 69, 56)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "1.2"}, {"groupId": "OG001", "value": "-0.4", "spread": "1.0"}, {"groupId": "OG002", "value": "-0.0", "spread": "1.0"}, {"groupId": "OG003", "value": "-0.5", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 76 (n=53, 59, 64, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.6", "spread": "1.2"}, {"groupId": "OG001", "value": "-2.0", "spread": "0.8"}, {"groupId": "OG002", "value": "0.1", "spread": "1.1"}, {"groupId": "OG003", "value": "-0.3", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 89 (n=49, 58, 56, 44)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4", "spread": "1.2"}, {"groupId": "OG001", "value": "-2.1", "spread": "1.0"}, {"groupId": "OG002", "value": "-1.6", "spread": "1.2"}, {"groupId": "OG003", "value": "-0.1", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 102 (n=42, 51, 51, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.1", "spread": "1.3"}, {"groupId": "OG001", "value": "-2.0", "spread": "1.2"}, {"groupId": "OG002", "value": "-0.4", "spread": "1.2"}, {"groupId": "OG003", "value": "-1.2", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 43, 37)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.9", "spread": "1.5"}, {"groupId": "OG001", "value": "-2.7", "spread": "1.3"}, {"groupId": "OG002", "value": "-1.1", "spread": "1.1"}, {"groupId": "OG003", "value": "-1.0", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 128 (n=31, 40, 41, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.8", "spread": "1.5"}, {"groupId": "OG001", "value": "-3.7", "spread": "1.2"}, {"groupId": "OG002", "value": "1.1", "spread": "1.3"}, {"groupId": "OG003", "value": "1.0", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 141 (n=29, 40, 35, 29)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.9", "spread": "1.5"}, {"groupId": "OG001", "value": "-2.0", "spread": "1.5"}, {"groupId": "OG002", "value": "1.1", "spread": "1.7"}, {"groupId": "OG003", "value": "1.3", "spread": "1.8"}]}]}, {"title": "Change from BL at Week 154 (n=27, 36, 33, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "1.7"}, {"groupId": "OG001", "value": "-0.8", "spread": "1.3"}, {"groupId": "OG002", "value": "2.5", "spread": "1.5"}, {"groupId": "OG003", "value": "1.3", "spread": "1.8"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "1.6"}, {"groupId": "OG001", "value": "0.3", "spread": "1.4"}, {"groupId": "OG002", "value": "2.4", "spread": "1.8"}, {"groupId": "OG003", "value": "-1.1", "spread": "1.8"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.4", "spread": "1.6"}, {"groupId": "OG001", "value": "-2.0", "spread": "2.0"}, {"groupId": "OG002", "value": "0.5", "spread": "1.7"}, {"groupId": "OG003", "value": "-0.8", "spread": "1.9"}]}]}, {"title": "Change from BL at Week 193 (n=19, 26, 27, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "2.3"}, {"groupId": "OG001", "value": "-1.6", "spread": "2.0"}, {"groupId": "OG002", "value": "0.5", "spread": "1.7"}, {"groupId": "OG003", "value": "-0.2", "spread": "2.3"}]}]}, {"title": "Change from BL at Week 206 (n=17, 24, 24, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "3.1"}, {"groupId": "OG001", "value": "-0.6", "spread": "2.4"}, {"groupId": "OG002", "value": "1.9", "spread": "1.6"}, {"groupId": "OG003", "value": "-0.2", "spread": "2.4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Changes From Baseline in Heart Rate During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "beats per minute", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Change from BL at Week 2 (n=96, 100, 94, 89)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.9"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.8"}, {"groupId": "OG002", "value": "0.2", "spread": "0.8"}, {"groupId": "OG003", "value": "0.3", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 4 (n=96, 100, 92, 91)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2", "spread": "0.9"}, {"groupId": "OG001", "value": "-1.1", "spread": "0.8"}, {"groupId": "OG002", "value": "0.7", "spread": "0.7"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 6 (n=91, 98, 88, 84)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.5", "spread": "0.9"}, {"groupId": "OG001", "value": "-0.6", "spread": "0.8"}, {"groupId": "OG002", "value": "-0.6", "spread": "0.8"}, {"groupId": "OG003", "value": "1.4", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 8 (n=94, 91, 91, 80)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.5", "spread": "0.9"}, {"groupId": "OG001", "value": "-0.9", "spread": "0.8"}, {"groupId": "OG002", "value": "0.2", "spread": "0.8"}, {"groupId": "OG003", "value": "-0.2", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 10 (n=51, 66, 51, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "1.2"}, {"groupId": "OG001", "value": "-1.5", "spread": "0.9"}, {"groupId": "OG002", "value": "-1.0", "spread": "1.2"}, {"groupId": "OG003", "value": "0.1", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 12 (n=82, 83, 87, 79)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "1.0"}, {"groupId": "OG001", "value": "-1.2", "spread": "0.8"}, {"groupId": "OG002", "value": "0.5", "spread": "0.9"}, {"groupId": "OG003", "value": "0.8", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 14 (n=65, 72, 65, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "1.1"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.9"}, {"groupId": "OG002", "value": "0.6", "spread": "1.1"}, {"groupId": "OG003", "value": "1.9", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 16 (n=87, 87, 81, 72)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "0.9"}, {"groupId": "OG001", "value": "-1.5", "spread": "0.9"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.9"}, {"groupId": "OG003", "value": "-0.1", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 18 (n=73, 69, 76, 66)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.0", "spread": "1.1"}, {"groupId": "OG001", "value": "-0.8", "spread": "1.1"}, {"groupId": "OG002", "value": "1.5", "spread": "1.0"}, {"groupId": "OG003", "value": "2.6", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 20 (n=84, 80, 76, 73)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "0.9"}, {"groupId": "OG001", "value": "-1.5", "spread": "0.9"}, {"groupId": "OG002", "value": "1.3", "spread": "0.9"}, {"groupId": "OG003", "value": "0.8", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 22 (n=78, 73, 76, 64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "1.0"}, {"groupId": "OG001", "value": "-0.3", "spread": "0.9"}, {"groupId": "OG002", "value": "0.9", "spread": "0.9"}, {"groupId": "OG003", "value": "1.5", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 24 (n=84, 83, 77, 75)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "1.1"}, {"groupId": "OG001", "value": "0.1", "spread": "1.1"}, {"groupId": "OG002", "value": "-0.7", "spread": "0.9"}, {"groupId": "OG003", "value": "-0.4", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 30 (n=79, 78, 79, 66)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "1.0"}, {"groupId": "OG001", "value": "-1.2", "spread": "1.1"}, {"groupId": "OG002", "value": "-0.7", "spread": "0.8"}, {"groupId": "OG003", "value": "-1.2", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 37 (n=77, 74, 71, 66)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "1.0"}, {"groupId": "OG001", "value": "-1.4", "spread": "0.9"}, {"groupId": "OG002", "value": "0.5", "spread": "1.0"}, {"groupId": "OG003", "value": "-0.9", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 50 (n=70, 73, 73, 62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.9"}, {"groupId": "OG001", "value": "-0.7", "spread": "1.1"}, {"groupId": "OG002", "value": "-0.2", "spread": "1.0"}, {"groupId": "OG003", "value": "-0.2", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 63 (n=62, 66, 69, 56)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "1.1"}, {"groupId": "OG001", "value": "-2.5", "spread": "1.0"}, {"groupId": "OG002", "value": "0.9", "spread": "1.1"}, {"groupId": "OG003", "value": "0.6", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 76 (n=53, 59, 64, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "1.4"}, {"groupId": "OG001", "value": "-3.3", "spread": "1.1"}, {"groupId": "OG002", "value": "0.4", "spread": "1.1"}, {"groupId": "OG003", "value": "0.2", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 89 (n=49, 58, 56, 44)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.5", "spread": "1.4"}, {"groupId": "OG001", "value": "-1.5", "spread": "1.2"}, {"groupId": "OG002", "value": "-0.9", "spread": "1.1"}, {"groupId": "OG003", "value": "-0.3", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 102 (n=42, 51, 51, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.8", "spread": "1.4"}, {"groupId": "OG001", "value": "-1.5", "spread": "1.4"}, {"groupId": "OG002", "value": "-0.1", "spread": "1.4"}, {"groupId": "OG003", "value": "-0.0", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 115 (n=34, 43, 43, 37)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.2", "spread": "1.7"}, {"groupId": "OG001", "value": "-2.3", "spread": "1.3"}, {"groupId": "OG002", "value": "1.0", "spread": "1.6"}, {"groupId": "OG003", "value": "0.8", "spread": "1.9"}]}]}, {"title": "Change from BL at Week 128 (n=31, 40, 41, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.1", "spread": "1.8"}, {"groupId": "OG001", "value": "-4.5", "spread": "1.6"}, {"groupId": "OG002", "value": "-0.7", "spread": "1.4"}, {"groupId": "OG003", "value": "1.7", "spread": "1.8"}]}]}, {"title": "Change from BL at Week 141 (n=29, 40, 35, 29)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.8", "spread": "1.4"}, {"groupId": "OG001", "value": "-3.5", "spread": "1.5"}, {"groupId": "OG002", "value": "-0.6", "spread": "1.6"}, {"groupId": "OG003", "value": "0.9", "spread": "1.7"}]}]}, {"title": "Change from BL at Week 154 (n=27, 36, 33, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "2.1"}, {"groupId": "OG001", "value": "-2.6", "spread": "1.6"}, {"groupId": "OG002", "value": "-1.3", "spread": "1.8"}, {"groupId": "OG003", "value": "-0.6", "spread": "2.0"}]}]}, {"title": "Change from BL at Week 167 (n=24, 33, 30, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.1", "spread": "1.9"}, {"groupId": "OG001", "value": "-0.8", "spread": "1.4"}, {"groupId": "OG002", "value": "-2.1", "spread": "2.4"}, {"groupId": "OG003", "value": "0.5", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 180 (n=21, 28, 28, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.1", "spread": "2.1"}, {"groupId": "OG001", "value": "-5.3", "spread": "1.8"}, {"groupId": "OG002", "value": "-2.0", "spread": "2.0"}, {"groupId": "OG003", "value": "-1.2", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 193 (n=19, 26, 27, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.6", "spread": "2.4"}, {"groupId": "OG001", "value": "-4.2", "spread": "1.8"}, {"groupId": "OG002", "value": "-2.4", "spread": "2.0"}, {"groupId": "OG003", "value": "1.1", "spread": "2.1"}]}]}, {"title": "Change from BL at Week 206 (n=17, 24, 24, 23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.3", "spread": "2.6"}, {"groupId": "OG001", "value": "-2.6", "spread": "1.9"}, {"groupId": "OG002", "value": "0.0", "spread": "2.7"}, {"groupId": "OG003", "value": "-0.8", "spread": "2.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period", "description": "The normality/abnormality of the ECG tracing was determined by the investigator.", "populationDescription": "Treated participants; BL n=number of participants at baseline", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Baseline, Weeks 12, 24, 76, 102, 154, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"title": "Normal BL, Normal Week 12 (BL n=65, 66, 67, 47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "57"}, {"groupId": "OG001", "value": "56"}, {"groupId": "OG002", "value": "59"}, {"groupId": "OG003", "value": "43"}]}]}, {"title": "Normal BL, Abnormal Week 12 (BL n=65, 66, 67, 47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "10"}, {"groupId": "OG002", "value": "8"}, {"groupId": "OG003", "value": "4"}]}]}, {"title": "Abnormal BL, Normal Week 12 (BL n=27, 32, 26, 43)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "9"}, {"groupId": "OG003", "value": "15"}]}]}, {"title": "Abnormal BL, Abnormal Week 12(BL n=27, 32, 26, 43)", "categories": [{"measurements": [{"groupId": "OG000", "value": "21"}, {"groupId": "OG001", "value": "26"}, {"groupId": "OG002", "value": "17"}, {"groupId": "OG003", "value": "28"}]}]}, {"title": "Normal BL, Normal Week 24 (BL n=53, 52, 47, 33)", "categories": [{"measurements": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "44"}, {"groupId": "OG002", "value": "43"}, {"groupId": "OG003", "value": "31"}]}]}, {"title": "Normal BL, Abnormal Week 24 (BL n=53, 52, 47, 33)", "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "8"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "2"}]}]}, {"title": "Abnormal BL, Normal Week 24 (BL n=19, 24, 21, 25)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "8"}, {"groupId": "OG002", "value": "9"}, {"groupId": "OG003", "value": "8"}]}]}, {"title": "Abnormal BL, Abnormal Week 24(BL n=19, 24, 21, 25)", "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "16"}, {"groupId": "OG002", "value": "12"}, {"groupId": "OG003", "value": "17"}]}]}, {"title": "Normal BL, Normal Week 76 (BL n=48, 49, 48, 36)", "categories": [{"measurements": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "44"}, {"groupId": "OG002", "value": "40"}, {"groupId": "OG003", "value": "30"}]}]}, {"title": "Normal BL, Abnormal Week 76 (BL n=48, 49, 48, 36)", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "5"}, {"groupId": "OG002", "value": "8"}, {"groupId": "OG003", "value": "6"}]}]}, {"title": "Abnormal BL, Normal Week 76 (BL n=19, 23, 21, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "8"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "13"}]}]}, {"title": "Abnormal BL, Abnormal Week 76(BL n=19, 23, 21, 27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "15"}, {"groupId": "OG002", "value": "15"}, {"groupId": "OG003", "value": "14"}]}]}, {"title": "Normal BL, Normal Week 102 (BL n=32, 32, 36, 22)", "categories": [{"measurements": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "26"}, {"groupId": "OG002", "value": "31"}, {"groupId": "OG003", "value": "18"}]}]}, {"title": "Normal BL, Abnormal Week 102 (BL n=32, 32, 36, 22)", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "5"}, {"groupId": "OG003", "value": "4"}]}]}, {"title": "Abnormal BL, Normal Week 102 (BL n=12, 18, 17, 20)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "5"}, {"groupId": "OG002", "value": "12"}, {"groupId": "OG003", "value": "11"}]}]}, {"title": "Abnormal BL,Abnormal Week 102(BL n=12, 18, 17, 20)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "13"}, {"groupId": "OG002", "value": "5"}, {"groupId": "OG003", "value": "9"}]}]}, {"title": "Normal BL, Normal Week 154 (BL n=20, 21, 26, 15)", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "17"}, {"groupId": "OG002", "value": "23"}, {"groupId": "OG003", "value": "14"}]}]}, {"title": "Normal BL, Abnormal Week 154 (BL n=20, 21, 26, 15)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "4"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Abnormal BL, Normal Week 154 (BL n=7, 16, 11, 13)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "4"}, {"groupId": "OG002", "value": "5"}, {"groupId": "OG003", "value": "7"}]}]}, {"title": "Abnormal BL, Abnormal Week 154(BL n=7, 16, 11, 13)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "12"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "6"}]}]}, {"title": "Normal BL, Normal Week 206 (BL n=15, 13, 20, 14)", "categories": [{"measurements": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "12"}, {"groupId": "OG002", "value": "18"}, {"groupId": "OG003", "value": "11"}]}]}, {"title": "Normal BL, Abnormal Week 206 (BL n=15, 13, 20, 14)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "2"}, {"groupId": "OG003", "value": "3"}]}]}, {"title": "Abnormal BL, Normal Week 206 (BL n=4, 13, 8, 11)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "3"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "4"}]}]}, {"title": "Abnormal BL, Abnormal Week 206 (BL n=4, 13, 8, 11)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "10"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Overall Summary of Adverse Events During ST+LT Treatment Period - Open-Label Cohort", "description": "AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks.", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "classes": [{"title": "At Least 1 AE", "categories": [{"measurements": [{"groupId": "OG000", "value": "49"}]}]}, {"title": "At Least 1 Related AE", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}]}]}, {"title": "Deaths", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "At Least 1 SAE", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}]}]}, {"title": "At Least 1 Related SAE", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Discontinuations Due to SAEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Discontinuations Due to AEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Marked Laboratory Abnormalities During ST + LT Treatment Period - Open-Label Cohort", "description": "A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: \\<0.9 x Pre-Rx \\& \\<=130mEq/L / high: \\>1.1 x Pre-Rx \\& \\>=150mEq/L; potassium, serum low: \\<=0.8 x Pre-Rx \\& \\>=6.0mEq/L / high: 1.2 x Pre-Rx \\& \\>=6.0mEq/L; LLN=lower limit of normal.", "populationDescription": "Number of Participants Analyzed=Treated participants; n=number of treated subjects with baseline value and at least one value during the ST + LT treatment period", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure was 34 weeks.", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}]}], "classes": [{"title": "Hemoglobin < 8 g/dL (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Hematocrit < 0.75 x pre-Rx (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Platelets < 50 x 10^9 c/L (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Platelets > 1.5 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Leukocytes < 2 x 1000 c/\u00b5L (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Neutrophils+Bands <1x1000 c/uL (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Eosinophils >0.9x1000 c/\u00b5L (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Lymphocytes <=0.75x1000 c/uL (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "ALP >3 x pre-Rx and >ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "ALP >1.5 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "AST >3 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "AST >5 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "AST >10 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "AST >20 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "ALT >3 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "ALT >5 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "ALT >10 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "ALT >20 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Bilirubin Total >2mg/dL (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Bilirubin Total >1.5xULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Bilirubin Total >2xULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "BUN >2 x pre-Rx and >ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Creatinine >2.5 mg/dL (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Glucose, Serum Fasting < 50 mg/dL (n=1)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Glucose, Serum Fasting > 500 mg/dL (n=1)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Glucose, Serum Unspec. < 50 mg/dL (n=1)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Glucose, Serum Unspec. > 500 mg/dL (n=1)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Glucose, Plasma Fasting <50 mg/dL (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Glucose,Plasma Fasting >500 mg/dL (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Glucose, Plasma Unspec. <50 mg/dL (n=65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Glucose,Plasma Unspec. >500 mg/dL (n=65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Sodium,Serum Low (see above) (n=65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Sodium,Serum High (see above) (n=65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Potassium,Serum Low (see above) (n=65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Potassium, Serum High (see above) (n=65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Chloride < 90 mEq/L (n=65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Chloride > 120 mEq/L (n=65)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Albumin < 0.9 LLN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Creatine Kinase > 5 x ULN (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Uric Acid > 1.5 x ULN (n=0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Protein Urine, >=2-4 (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Blood Urine, >=2-4 (n=64)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}, {"title": "Red Blood Cells Urine >=2-4 (n=58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}]}]}, {"title": "White Blood Cells Urine >=2-4 (n=58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "All Reported Hypoglycemic Adverse Events During ST + LT Treatment Period", "description": "Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which included hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.", "populationDescription": "Treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "11"}, {"groupId": "OG002", "value": "10"}, {"groupId": "OG003", "value": "9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Confirmed Hypoglycemia During ST + LT Treatment Period", "description": "'Confirmed' = recorded on the hypoglycemia AE case report form page with a fingerstick glucose \\<= 50 mg/dL and associated symptoms", "populationDescription": "Treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "106"}, {"groupId": "OG002", "value": "98"}, {"groupId": "OG003", "value": "95"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "All Reported Hypoglycemic Adverse Events During ST + LT Treatment Period - Open-Label Cohort", "description": "Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which included hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.", "populationDescription": "Treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks.", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Confirmed Hypoglycemia During ST + LT Treatment Period - Open-Label Cohort", "description": "'Confirmed' = recorded on the hypoglycemia AE case report form page with a fingerstick glucose \\<= 50 mg/dL and associated symptoms", "populationDescription": "Treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks.", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period - Open Label Cohort", "description": "The normality/abnormality of the ECG tracing was determined by the investigator.", "populationDescription": "Treated participants; BL n=number of participants at baseline", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Baseline, Weeks 12, 24, 76, 102, 154, 206", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "classes": [{"title": "Normal BL, Normal Week 12 (BL n=23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "19"}]}]}, {"title": "Normal BL, Abnormal Week 12 (BL n=23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}, {"title": "Abnormal BL, Normal Week 12 (BL n=18)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}]}]}, {"title": "Abnormal BL, Abnormal Week 12 (BL n=18)", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}]}]}, {"title": "Normal BL, Normal Week 24 (BL n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}]}]}, {"title": "Normal BL, Abnormal Week 24 (BL n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Abnormal BL, Normal Week 24 (BL n=6)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Abnormal BL, Abnormal Week 24(BL n=6)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}, {"title": "Normal BL, Normal Week 76 (BL n=17)", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}]}]}, {"title": "Normal BL, Abnormal Week 76 (BL n=17)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}, {"title": "Abnormal BL, Normal Week 76 (BL n=13)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}, {"title": "Abnormal BL, Abnormal Week 76 (BL n=13)", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}]}]}, {"title": "Normal BL, Normal Week 102 (BL n=8)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}]}]}, {"title": "Normal BL, Abnormal Week 102 (BL n=8)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Abnormal BL, Normal Week 102 (BL n=4)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Abnormal BL, Abnormal Week 102 (BL n=4)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}]}]}, {"title": "Normal BL, Normal Week 154 (BL n=4)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}]}]}, {"title": "Normal BL, Abnormal Week 154 (BL n=4)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Abnormal BL, Normal Week 154 (BL n=2)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Abnormal BL, Abnormal Week 154 (BL n=2)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Normal BL, Normal Week 206 (BL n=3)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Normal BL, Abnormal Week 206 (BL n=3)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Abnormal BL, Normal Week 206 (BL n=1)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Abnormal BL, Abnormal Week 206 (BL n=1)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Changes From Baseline in Systolic Blood Pressure During the ST + LT Period - Open Label Cohort", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mmHg", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "classes": [{"title": "Change from BL at Week 2 (n=62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.4", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 4 (n=59)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.8", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 6 (n=60)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.7", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 8 (n=49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.1", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 10 (n=24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.2", "spread": "2.8"}]}]}, {"title": "Change from BL at Week 12 (n=47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.9", "spread": "1.8"}]}]}, {"title": "Change from BL at Week 14 (n=35)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.1", "spread": "2.0"}]}]}, {"title": "Change from BL at Week 16 (n=46)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.9", "spread": "2.2"}]}]}, {"title": "Change from BL at Week 18 (n=42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.8", "spread": "2.0"}]}]}, {"title": "Change from BL at Week 20 (n=45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.6", "spread": "2.0"}]}]}, {"title": "Change from BL at Week 22 (n=44)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.0", "spread": "2.1"}]}]}, {"title": "Change from BL at Week 24 (n=44)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.3", "spread": "2.1"}]}]}, {"title": "Change from BL at Week 30 (n=40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.8", "spread": "1.8"}]}]}, {"title": "Change from BL at Week 37 (n=35)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.7", "spread": "1.8"}]}]}, {"title": "Change from BL at Week 50 (n=36)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.6", "spread": "2.1"}]}]}, {"title": "Change from BL at Week 63 (n=26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "2.7"}]}]}, {"title": "Change from BL at Week 76 (n=24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.9", "spread": "2.1"}]}]}, {"title": "Change from BL at Week 89 (n=23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.0", "spread": "2.6"}]}]}, {"title": "Change from BL at Week 102 (n=15)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.9", "spread": "2.4"}]}]}, {"title": "Change from BL at Week 115 (n=13)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-6.6", "spread": "3.6"}]}]}, {"title": "Change from BL at Week 128 (n=11)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.6", "spread": "4.3"}]}]}, {"title": "Change from BL at Week 141 (n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-7.2", "spread": "4.4"}]}]}, {"title": "Change from BL at Week 154 (n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.7", "spread": "4.7"}]}]}, {"title": "Change from BL at Week 167 (n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.2", "spread": "4.4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period - Open Label Cohort", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mmHg", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "classes": [{"title": "Change from BL at Week 2 (n=62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.7", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 4 (n=59)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.7", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 6 (n=60)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.8", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 8 (n=49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 10 (n=24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.0", "spread": "2.0"}]}]}, {"title": "Change from BL at Week 12 (n=47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.7", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 14 (n=35)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.5", "spread": "1.7"}]}]}, {"title": "Change from BL at Week 16 (n=46)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.8", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 18 (n=42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.3", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 20 (n=45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.1", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 22 (n=44)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.8", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 24 (n=44)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.4", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 30 (n=40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.8", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 37 (n=35)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 50 (n=36)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.3", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 63 (n=26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.9", "spread": "1.8"}]}]}, {"title": "Change from BL at Week 76 (n=24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.0", "spread": "2.0"}]}]}, {"title": "Change from BL at Week 89 (n=23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.6", "spread": "1.9"}]}]}, {"title": "Change from BL at Week 102 (n=15)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "3.0"}]}]}, {"title": "Change from BL at Week 115 (n=13)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.1", "spread": "2.5"}]}]}, {"title": "Change from BL at Week 128 (n=11)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.7", "spread": "2.8"}]}]}, {"title": "Change from BL at Week 141 (n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-6.0", "spread": "2.6"}]}]}, {"title": "Change from BL at Week 154 (n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.5", "spread": "2.7"}]}]}, {"title": "Change from BL at Week 167 (n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.5", "spread": "2.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Changes From Baseline in Heart Rate During the ST + LT Period - Open Label Cohort", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "beats per minute", "timeFrame": "Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167", "groups": [{"id": "OG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "classes": [{"title": "Change from BL at Week 2 (n=62)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 4 (n=59)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 6 (n=60)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 8 (n=49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 10 (n=23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.8", "spread": "2.1"}]}]}, {"title": "Change from BL at Week 12 (n=47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.0", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 14 (n=34)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 16 (n=46)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 18 (n=42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 20 (n=45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.6", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 22 (n=43)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 24 (n=44)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 30 (n=40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.6", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 37 (n=35)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.6", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 50 (n=36)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.9", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 63 (n=26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.0", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 76 (n=24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "2.5"}]}]}, {"title": "Change from BL at Week 89 (n=23)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.3", "spread": "1.8"}]}]}, {"title": "Change from BL at Week 102 (n=15)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 115 (n=13)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.7", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 128 (n=11)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.6", "spread": "3.6"}]}]}, {"title": "Change from BL at Week 141 (n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.4", "spread": "1.7"}]}]}, {"title": "Change from BL at Week 154 (n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.5", "spread": "2.6"}]}]}, {"title": "Change from BL at Week 167 (n=10)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.9", "spread": "3.3"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "Open-Label Treatment Cohort (Direct Enrollees)", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).", "seriousNumAffected": 6, "seriousNumAtRisk": 66, "otherNumAffected": 39, "otherNumAtRisk": 66}, {"id": "EG001", "title": "Placebo", "description": "Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)", "seriousNumAffected": 11, "seriousNumAtRisk": 95, "otherNumAffected": 63, "otherNumAtRisk": 95}, {"id": "EG002", "title": "Saxagliptin 10 mg", "description": "Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).", "seriousNumAffected": 9, "seriousNumAtRisk": 98, "otherNumAffected": 69, "otherNumAtRisk": 98}, {"id": "EG003", "title": "Saxagliptin 2.5 mg", "description": "Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).", "seriousNumAffected": 11, "seriousNumAtRisk": 102, "otherNumAffected": 72, "otherNumAtRisk": 102}, {"id": "EG004", "title": "Saxagliptin 5 mg", "description": "Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).", "seriousNumAffected": 18, "seriousNumAtRisk": 106, "otherNumAffected": 77, "otherNumAtRisk": 106}], "seriousEvents": [{"term": "TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "ANGINA UNSTABLE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "ATRIAL FIBRILLATION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 106}]}, {"term": "AORTIC VALVE STENOSIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "MYOCARDIAL INFARCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "CORONARY ARTERY DISEASE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "CARDIAC FAILURE CONGESTIVE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "ACUTE MYOCARDIAL INFARCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "SUPRAVENTRICULAR TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "HYPOTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "HYPERTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "ORTHOSTATIC HYPOTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "ADRENAL MASS", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "CHOLELITHIASIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "GALLBLADDER POLYP", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "CHOLECYSTITIS ACUTE", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "SYNCOPE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "SCIATICA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "VASCULAR HEADACHE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "IVTH NERVE PARALYSIS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "CEREBROVASCULAR ACCIDENT", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 106}]}, {"term": "ABDOMINAL PAIN", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "INTESTINAL MASS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "ABDOMINAL PAIN UPPER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "ABDOMINAL TENDERNESS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "SMALL INTESTINAL OBSTRUCTION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "GANGRENE", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "PNEUMONIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "CELLULITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 106}]}, {"term": "HEPATITIS C", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "APPENDICITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "TUBERCULOSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "PYELONEPHRITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "GASTROENTERITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "HAEMATOMA INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "NEPHROLITHIASIS", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "DEHYDRATION", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "RASH", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "TESTICULAR PAIN", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "BENIGN PROSTATIC HYPERPLASIA", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "WOUND", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "MULTIPLE FRACTURES", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "ABORTION SPONTANEOUS", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "BACK PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "OSTEOARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 106}]}, {"term": "MUSCULOSKELETAL PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "PLEURAL EFFUSION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "CHEST PAIN", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "NON-CARDIAC CHEST PAIN", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "COLON CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "BRAIN NEOPLASM", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "PROSTATE CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "CERVIX CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "MALIGNANT MELANOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "BASAL CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "RENAL CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}, {"term": "LUNG NEOPLASM MALIGNANT", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "SQUAMOUS CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 106}]}, {"term": "SQUAMOUS CELL CARCINOMA OF SKIN", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 106}]}], "otherEvents": [{"term": "HYPERTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 5, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 7, "numAtRisk": 106}]}, {"term": "INSOMNIA", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 3, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 6, "numAtRisk": 106}]}, {"term": "DEPRESSION", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 7, "numAtRisk": 106}]}, {"term": "HEADACHE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 16, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 16, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 7, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 13, "numAtRisk": 106}]}, {"term": "DIZZINESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 9, "numAtRisk": 106}]}, {"term": "NAUSEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 7, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 6, "numAtRisk": 106}]}, {"term": "VOMITING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 7, "numAtRisk": 106}]}, {"term": "DIARRHOEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 14, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 106}]}, {"term": "TOOTHACHE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 3, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 3, "numAtRisk": 106}]}, {"term": "CONSTIPATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 3, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 5, "numAtRisk": 106}]}, {"term": "ABDOMINAL PAIN", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 7, "numAtRisk": 106}]}, {"term": "INFLUENZA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 15, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 11, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 9, "numAtRisk": 106}]}, {"term": "SINUSITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 9, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 106}]}, {"term": "BRONCHITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 5, "numAtRisk": 106}]}, {"term": "PHARYNGITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 6, "numAtRisk": 106}]}, {"term": "NASOPHARYNGITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 12, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 14, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 11, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 13, "numAtRisk": 106}]}, {"term": "URINARY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 8, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 14, "numAtRisk": 106}]}, {"term": "UPPER RESPIRATORY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 9, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 15, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 14, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 12, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 16, "numAtRisk": 106}]}, {"term": "RASH", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 7, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 106}]}, {"term": "CONTUSION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 7, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 106}]}, {"term": "BACK PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 11, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 12, "numAtRisk": 106}]}, {"term": "ARTHRALGIA", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 16, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 8, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 6, "numAtRisk": 106}]}, {"term": "PAIN IN EXTREMITY", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 9, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 106}]}, {"term": "MUSCULOSKELETAL PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 5, "numAtRisk": 106}]}, {"term": "COUGH", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 5, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 4, "numAtRisk": 106}]}, {"term": "OROPHARYNGEAL PAIN", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 66}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 95}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 98}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 102}, {"groupId": "EG004", "numAffected": 3, "numAtRisk": 106}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication."}, "pointOfContact": {"title": "Boaz Hirschberg", "organization": "AstraZeneca Pharmaceuticals", "email": "ClinicalTrialTransparency@astrazeneca.com"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000003924", "term": "Diabetes Mellitus, Type 2"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes", "relevance": "HIGH"}, {"id": "M7119", "name": "Diabetes Mellitus, Type 2", "asFound": "Diabetes Mellitus, Type 2", "relevance": "HIGH"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}, {"id": "C000502994", "term": "Saxagliptin"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000054795", "term": "Incretins"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000054873", "term": "Dipeptidyl-Peptidase IV Inhibitors"}, {"id": "D000011480", "term": "Protease Inhibitors"}, {"id": "D000004791", "term": "Enzyme Inhibitors"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M228152", "name": "Saxagliptin", "asFound": "Manufacturer", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}, {"id": "M27905", "name": "Incretins", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M27957", "name": "Dipeptidyl-Peptidase IV Inhibitors", "relevance": "LOW"}, {"id": "M19609", "name": "HIV Protease Inhibitors", "relevance": "LOW"}, {"id": "M14343", "name": "Protease Inhibitors", "relevance": "LOW"}, {"id": "M7951", "name": "Enzyme Inhibitors", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Infe", "name": "Anti-Infective Agents"}]}}, "hasResults": true}